EGFR
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
Y Sites Probabilities
Log-Odds: Y Sites / Y Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0MZ66 | Y24 | Sugiyama | SHTN1 KIAA1598 | sDEEKQLQLITsLKEQAIGEyEDLRAENQKTKEKCDKIRQE |
| A1L429 | Y10 | Sugiyama | GAGE12B; GAGE12C; GAGE12D; GAGE12E | ___________MSWRGRsTyyWPRPRRYVQPPEMIGPMRPE |
| A1L429 | Y9 | Sugiyama | GAGE12B; GAGE12C; GAGE12D; GAGE12E | ____________MSWRGRsTyyWPRPRRYVQPPEMIGPMRP |
| A5A3E0 | Y1062 | Sugiyama | POTEF A26C1B | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCL_______ |
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| A6NDE8 | Y10 | Sugiyama | GAGE12H | ___________MSWRGRsTyyWPRPRRYVQPPEMIGPMRPE |
| A6NDE8 | Y9 | Sugiyama | GAGE12H | ____________MSWRGRsTyyWPRPRRYVQPPEMIGPMRP |
| A6NER3 | Y10 | Sugiyama | GAGE12J | ___________MSWRGRsTyyWPRPRPYVQPPEMIGPMRPE |
| A6NER3 | Y9 | Sugiyama | GAGE12J | ____________MSWRGRsTyyWPRPRPYVQPPEMIGPMRP |
| O00116 | Y645 | Sugiyama | AGPS AAG5 | QWLKESIsDVGFGMLKSVKEyVDPNNIFGNRNLL_______ |
| O00151 | Y321 | Sugiyama | PDLIM1 CLIM1 CLP36 | VEDQIyCEKHARERVtPPEGyEVVTVFPK____________ |
| O00193 | Y84 | Sugiyama | SMAP C11orf58 | TSHFRTGEEDKKINEELEsQyQQsMDsKLSGRYRRHCGLGF |
| O00232 | S21 | Sugiyama | PSMD12 | MADGGSERADGRIVKMEVDysATVDQRLPECAKLAKEGRLQ |
| O00233 | Y41 | Sugiyama | PSMD9 | SDVQELMRRKEEIEAQIKANyDVLEsQKGIGMNEPLVDCEG |
| O00233 | Y70 | Sugiyama | PSMD9 | IGMNEPLVDCEGyPRSDVDLyQVRTARHNIICLQNDHKAVM |
| O00291 | Y152 | PSP | HIP1 | SEGYGQLCSIYLKLLRTKMEyHTKNPRFPGNLQMSDRQLDE |
| O00429 | Y266 | Sugiyama | DNM1L DLP1 DRP1 | NRSQLDINNKKSVTDsIRDEyAFLQKKYPSLANRNGTKYLA |
| O00469 | Y444 | Sugiyama | PLOD2 | LWSNFWGALSPDGYYARsEDyVDIVQGNRVGVWNVPYMANV |
| O00488 | Y97 | Sugiyama | ZNF593 ZT86 | KTHFRSKDHKKRLKQLsVEPysQEEAERAAGMGSYVPPRRL |
| O00625 | Y131 | Sugiyama | PIR | AHGLQLWVNLRSSEKMVEPQyQELKSEEIPKPSKDGVTVAV |
| O00767 | Y14 | EPSD|PSP | SCD FADS5 SCD1 SCDOS | _______MPAHLLQDDISSSyTTTTTITAPPSRVLQNGGDK |
| O00767 | Y41 | EPSD|PSP | SCD FADS5 SCD1 SCDOS | TAPPSRVLQNGGDKLETMPLyLEDDIRPDIKDDIyDPTYKD |
| O00767 | Y55 | EPSD|PSP | SCD FADS5 SCD1 SCDOS | LETMPLyLEDDIRPDIKDDIyDPTYKDKEGPSPKVEYVWRN |
| O14561 | Y147 | Sugiyama | NDUFAB1 | GFEIPDIDAEKLMCPQEIVDyIADKKDVyE___________ |
| O14561 | Y155 | Sugiyama | NDUFAB1 | AEKLMCPQEIVDyIADKKDVyE___________________ |
| O14639 | Y383 | Sugiyama | ABLIM1 ABLIM KIAA0059 LIMAB1 | sIPGsPGHtIyAKVDNEILDyKDLAAIPKVKAIYDIERPDL |
| O14818 | Y176 | Sugiyama | PSMA7 HSPC | WKANAIGRGAKSVREFLEKNyTDEAIETDDLTIKLVIKALL |
| O14828 | Y41 | SIGNOR|iPTMNet|EPSD | SCAMP3 C1orf3 PROPIN1 | FQDPAVIQHRPsRQyATLDVyNPFETREPPPAyEPPAPAPL |
| O14939 | Y179 | SIGNOR|iPTMNet|EPSD | PLD2 | AASKQKYLENyLNRLLtMSFyRNYHAMTEFLEVSQLSFIPD |
| O14939 | Y296 | EPSD|PSP | PLD2 | ARHGVRIDTSHRSLILKCSSyRQARWWAQEITELAQGPGRD |
| O14950 | Y143 | Sugiyama | MYL12B MRLC2 MYLC2B | LRELLttMGDRFtDEEVDELyREAPIDKKGNFNyIEFtRIL |
| O14950 | Y156 | Sugiyama | MYL12B MRLC2 MYLC2B | DEEVDELyREAPIDKKGNFNyIEFtRILKHGAKDKDD____ |
| O14964 | Y329 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | HGS HRS | ssPVNssAPLAEDIDPELARyLNRNyWEKKQEEARKSPTPS |
| O14964 | Y334 | SIGNOR | HGS HRS | ssAPLAEDIDPELARyLNRNyWEKKQEEARKSPTPSAPVPL |
| O14974 | S910 | Sugiyama | PPP1R12A MBS MYPT1 | yETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDST |
| O14974 | Y901 | Sugiyama | PPP1R12A MBS MYPT1 | EtQtDsIsRyETssTsAGDRyDsLLGRsGsysYLEERKPYS |
| O14974 | Y911 | Sugiyama | PPP1R12A MBS MYPT1 | ETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDSTD |
| O14979 | Y167 | Sugiyama | HNRNPDL HNRPDL JKTBP | DGKMFIGGLSWDTsKKDLtEyLSRFGEVVDCtIKTDPVTGR |
| O15126 | Y37 | SIGNOR|iPTMNet|EPSD | SCAMP1 SCAMP | PFKDPSVTQVTRNVPPGLDEyNPFsDsRtPPPGGVKMPNVP |
| O15173 | T211 | Sugiyama | PGRMC2 DG6 PMBP | KEKYDYVGRLLKPGEEPsEytDEEDtKDHNKQD________ |
| O15173 | Y210 | Sugiyama | PGRMC2 DG6 PMBP | FKEKYDYVGRLLKPGEEPsEytDEEDtKDHNKQD_______ |
| O15230 | Y81 | Sugiyama | LAMA5 KIAA0533 KIAA1907 | SATCGEEAPARGSPRPTEDLyCKLVGGPVAGGDPNQTIRGQ |
| O15357 | Y1135 | Sugiyama | INPPL1 SHIP2 | SGDDRSCSVLQMAKTLSEVDyAPAGPARSALLPGPLELQPP |
| O15371 | Y50 | Sugiyama | EIF3D EIF3S7 | yQPFsKGDRLGKVADWtGAtyQDKRYTNKYSSQFGGGSQYA |
| O15455 | Y858 | EPSD|PSP | TLR3 | QAIEQNLDSIILVFLEEIPDyKLNHALCLRRGMFKSHCILN |
| O15492 | Y168 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | RGS16 RGSR | TATCFDAAQGKTRTLMEKDSyPRFLKSPAyRDLAAQASAAS |
| O15492 | Y177 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | RGS16 RGSR | GKTRTLMEKDSyPRFLKSPAyRDLAAQASAASATLSSCsLD |
| O43164 | Y63 | Sugiyama | PJA2 KIAA0438 RNF131 | VSFKPCMTRHERSLGRAGDDyEVLELDDVPKENssGssPLD |
| O43390 | Y136 | Sugiyama | HNRNPR HNRPR | QESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O43390 | Y434 | Sugiyama | HNRNPR HNRPR | KKRKERQAARQAsRstAyEDyyyHPPPRMPPPIRGRGRGGG |
| O43390 | Y436 | Sugiyama | HNRNPR HNRPR | RKERQAARQAsRstAyEDyyyHPPPRMPPPIRGRGRGGGRG |
| O43399 | Y106 | Sugiyama | TPD52L2 | LGELKQNLsRsWHDVQVssAyVKTSEKLGEWNEKVTQSDLy |
| O43707 | Y212 | Sugiyama | ACTN4 | WKDGLAFNALIHRHRPELIEyDKLRKDDPVTNLNNAFEVAE |
| O43707 | Y234 | Sugiyama | ACTN4 | KLRKDDPVTNLNNAFEVAEKyLDIPKMLDAEDIVNtARPDE |
| O43707 | Y441 | Sugiyama | ACTN4 | KAsIHEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEs |
| O43707 | Y878 | Sugiyama | ACTN4 | DKNFITAEELRRELPPDQAEyCIARMAPyQGPDAVPGALDy |
| O43719 | Y650 | Sugiyama | HTATSF1 | EEDtyEKVFDDEsDEKEDEEyADEKGLEAADKKAEEGDADE |
| O43823 | Y170 | Sugiyama | AKAP8 AKAP95 | ySyDyEFDLGSDRNGsFGGQySECRDPARERGSLDGFMRGR |
| O43852 | Y106 | Sugiyama | CALU | GFVtVDELKDWIKFAQKRWIyEDVERQWKGHDLNEDGLVsW |
| O43852 | Y185 | Sugiyama | CALU | KDGDLIATKEEFtAFLHPEEyDyMKDIVVQEtMEDIDKNAD |
| O43852 | Y187 | Sugiyama | CALU | GDLIATKEEFtAFLHPEEyDyMKDIVVQEtMEDIDKNADGF |
| O43852 | Y213 | Sugiyama | CALU | VQEtMEDIDKNADGFIDLEEyIGDMysHDGNtDEPEWVKTE |
| O43852 | Y218 | Sugiyama | CALU | EDIDKNADGFIDLEEyIGDMysHDGNtDEPEWVKTEREQFV |
| O43852 | Y263 | Sugiyama | CALU | KNRDGKMDKEEtKDWILPsDyDHAEAEARHLVyEsDQNKDG |
| O43852 | Y47 | Sugiyama | CALU | RVHHEPQLsDKVHNDAQsFDyDHDAFLGAEEAKtFDQLtPE |
| O43865 | Y28 | Sugiyama | AHCYL1 DCAL IRBIT XPVKONA | PLPGVGEELKQAKEIEDAEKysFMATVTKAPKKQIQFADDM |
| O60361 | Y136 | Sugiyama | NME2P1 | SLRFKPEELVDYKSCAHDWVyE___________________ |
| O60506 | Y133 | Sugiyama | SYNCRIP HNRPQ NSAP1 | ADSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O60664 | Y95 | Sugiyama | PLIN3 M6PRBP1 TIP47 | VsGAQPILSKLEPQIAsAsEyAHRGLDKLEENLPILQQPTE |
| O60716 | Y228 | SIGNOR|iPTMNet|EPSD|Sugiyama | CTNND1 KIAA0384 | yPPDGysRHyEDGyPGGsDNyGsLsRVtRIEERyRPsMEGy |
| O60716 | Y280 | Sugiyama | CTNND1 KIAA0384 | QPQVRVGGssVDLHRFHPEPyGLEDDQRsMGyDDLDyGMMs |
| O60739 | Y30 | Sugiyama | EIF1B | FDPFADATKGDDLLPAGTEDyIHIRIQQRNGRKtLttVQGI |
| O60828 | Y209 | Sugiyama | PQBP1 NPW38 JM26 | KSKKAVSRKDEELDPMDPSsysDAPRGTWstGLPKRNEAKT |
| O60841 | Y134 | Sugiyama | EIF5B IF2 KIAA0741 | EELEDKDsKSKKTAKPKVEMysGsDDDDDFNKLPKKAKGKA |
| O60934 | Y679 | Sugiyama | NBN NBS NBS1 P95 | FRSLVIKNSTSRNPSGINDDyGQLKNFKKFKKVTYPGAGKL |
| O75116 | Y936 | Sugiyama | ROCK2 KIAA0619 | EITLTKADSEQLARsIAEEQysDLEKEKIMKELEIKEMMAR |
| O75190 | Y4 | Sugiyama | DNAJB6 HSJ2 MRJ MSJ1 | _________________MVDyyEVLGVQRHAsPEDIKKAYR |
| O75190 | Y5 | Sugiyama | DNAJB6 HSJ2 MRJ MSJ1 | ________________MVDyyEVLGVQRHAsPEDIKKAYRK |
| O75190 | Y53 | Sugiyama | DNAJB6 HSJ2 MRJ MSJ1 | DKNPENKEEAERKFKQVAEAyEVLSDAKKRDIYDKYGKEGL |
| O75208 | Y93 | Sugiyama | COQ9 C16orf49 HSPC326 PSEC0129 | PEssHsPPRYTDQGGEEEEDyEsEEQLQHRILTAALEFVPA |
| O75347 | Y75 | Sugiyama | TBCA | EILQEsRMMIPDCQRRLEAAyLDLQRILENEKDLEEAEEyK |
| O75347 | Y94 | Sugiyama | TBCA | AyLDLQRILENEKDLEEAEEyKEARLVLDsVKLEA______ |
| O75348 | Y47 | Sugiyama | ATP6V1G1 ATP6G ATP6G1 ATP6J | KRKNRRLKQAKEEAQAEIEQyRLQREKEFKAKEAAALGsRG |
| O75369 | T907 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | PLPGDAVKDLDIIDNyDysHtVKYtPtQQGNMQVLVTYGGD |
| O75886 | Y192 | SIGNOR|iPTMNet|EPSD | STAM2 HBP | KAIELSLQEQKQQHTETKSLyPSSEIQLNNKVARKVRALYD |
| O76087 | Y10 | Sugiyama | GAGE7 GAGE12I GAGE7B | ___________MSWRGRsTyyWPRPRRYVQPPEMIGPMRPE |
| O76087 | Y9 | Sugiyama | GAGE7 GAGE12I GAGE7B | ____________MSWRGRsTyyWPRPRRYVQPPEMIGPMRP |
| O94842 | Y591 | Sugiyama | TOX4 C14orf92 KIAA0737 | RCVRsGCENPPIVSKDWDNEyCSNECVVKHCRDVFLAWVAS |
| O94906 | Y105 | Sugiyama | PRPF6 C20orf14 | AGSLFSSGPYEKDDEEADAIyAALDKRMDERRKERREQREK |
| O94919 | Y134 | Sugiyama | ENDOD1 KIAA0830 | EAEAITSVNSLGSKQALNtDyLDsDyQRGQLYPFSLSSDVQ |
| O95218 | Y114 | Sugiyama | ZRANB2 ZIS ZNF265 | AKLEERtGYGGGFNERENVEyIEREEsDGEyDEFGRKKKKY |
| O95218 | Y124 | Sugiyama | ZRANB2 ZIS ZNF265 | GGFNERENVEyIEREEsDGEyDEFGRKKKKYRGKAVGPAsI |
| O95218 | Y167 | Sugiyama | ZRANB2 ZIS ZNF265 | EVEDKEsEGEEEDEDEDLsKyKLDEDEDEDDADLsKyNLDA |
| O95297 | Y263 | Sugiyama | MPZL1 PZR UNQ849/PRO1787 | QLDHsGGHHSDKINKSEsVVyADIRKN______________ |
| O95347 | Y938 | Sugiyama | SMC2 CAPE SMC2L1 PRO0324 | SKHKREAEDGAAKVSKMLKDyDWINAERHLFGQPNSAYDFK |
| O95359 | Y2527 | Sugiyama | TACC2 | ETKFssPtEELDyRNsYEIEyMEKIGssLPQDDDAPKKQAL |
| O95425 | Y132 | Sugiyama | SVIL | RRRQLAEKyGLTLDPEADsEyLsRYTKSRKEPDAVEKRGGK |
| O95477 | S2054 | SIGNOR|EPSD|PSP | ABCA1 ABC1 CERP | LVKYGEKYAGNYSGGNKRKLsTAMALIGGPPVVFLDEPTTG |
| O95757 | Y600 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | IDLPIQssLCRQLGQDLLNsyIENEGKMIMQDKLEKERNDA |
| O95757 | Y627 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | MIMQDKLEKERNDAKNAVEEyVyDFRDRLGtVYEKFITPED |
| O95757 | Y629 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | MQDKLEKERNDAKNAVEEyVyDFRDRLGtVYEKFITPEDLS |
| O95817 | T242 | Sugiyama | BAG3 BIS | QPsFHQAQKTHyPAQQGEyQtHQPVyHKIQGDDWEPRPLRA |
| O95817 | Y240 | Sugiyama | BAG3 BIS | AAQPsFHQAQKTHyPAQQGEyQtHQPVyHKIQGDDWEPRPL |
| O95817 | Y247 | Sugiyama | BAG3 BIS | QAQKTHyPAQQGEyQtHQPVyHKIQGDDWEPRPLRAAsPFR |
| O95926 | Y210 | Sugiyama | SYF2 CBPIN GCIPIP | IEKRDKYSRRRPYNDDADIDyINERNAKFNKKAERFYGKYT |
| P00505 | Y96 | Sugiyama | GOT2 KYAT4 | VLPSVRKAEAQIAAKNLDKEyLPIGGLAEFCKASAELALGE |
| P00533 | S1057 | Sugiyama | EGFR ERBB ERBB1 HER1 | sLsAtsNNstVACIDRNGLQsCPIKEDsFLQRyssDPtGAL |
| P00533 | S1162 | Sugiyama | EGFR ERBB ERBB1 HER1 | VQPtCVNSTFDsPAHWAQKGsHQIsLDNPDyQQDFFPKEAK |
| P00533 | S1166 | Sugiyama | EGFR ERBB ERBB1 HER1 | CVNSTFDsPAHWAQKGsHQIsLDNPDyQQDFFPKEAKPNGI |
| P00533 | S1190 | Sugiyama | EGFR ERBB ERBB1 HER1 | PDyQQDFFPKEAKPNGIFKGstAENAEyLRVAPQsSEFIGA |
| P00533 | S991 | Sugiyama | EGFR ERBB ERBB1 HER1 | MARDPQRyLVIQGDERMHLPsPtDsNFyRALMDEEDMDDVV |
| P00533 | T693 | Sugiyama | EGFR ERBB ERBB1 HER1 | IVRKRtLRRLLQERELVEPLtPsGEAPNQALLRILKETEFK |
| P00533 | T993 | Sugiyama | EGFR ERBB ERBB1 HER1 | RDPQRyLVIQGDERMHLPsPtDsNFyRALMDEEDMDDVVDA |
| P00533 | Y1016 | GPS6|SIGNOR|iPTMNet|EPSD|PSP | EGFR ERBB ERBB1 HER1 | NFyRALMDEEDMDDVVDADEyLIPQQGFFssPStsRTPLLs |
| P00533 | Y1069 | SIGNOR|iPTMNet|EPSD | EGFR ERBB ERBB1 HER1 | CIDRNGLQsCPIKEDsFLQRyssDPtGALtEDsIDDtFLPV |
| P00533 | Y1092 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | EGFR ERBB ERBB1 HER1 | DPtGALtEDsIDDtFLPVPEyINQsVPKRPAGsVQNPVyHN |
| P00533 | Y1110 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | EGFR ERBB ERBB1 HER1 | PEyINQsVPKRPAGsVQNPVyHNQPLNPAPsRDPHyQDPHs |
| P00533 | Y1172 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP|Sugiyama | EGFR ERBB ERBB1 HER1 | DsPAHWAQKGsHQIsLDNPDyQQDFFPKEAKPNGIFKGstA |
| P00533 | Y1197 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP|Sugiyama | EGFR ERBB ERBB1 HER1 | FPKEAKPNGIFKGstAENAEyLRVAPQsSEFIGA_______ |
| P00533 | Y764 | Sugiyama | EGFR ERBB ERBB1 HER1 | IKELREATSPKANKEILDEAyVMAsVDNPHVCRLLGICLTS |
| P00533 | Y827 | Sugiyama | EGFR ERBB ERBB1 HER1 | DNIGSQYLLNWCVQIAKGMNyLEDRRLVHRDLAARNVLVKT |
| P00533 | Y869 | SIGNOR|EPSD|PSP|Sugiyama | EGFR ERBB ERBB1 HER1 | QHVKITDFGLAKLLGAEEKEyHAEGGKVPIKWMALESILHR |
| P00533 | Y978 | GPS6|Sugiyama | EGFR ERBB ERBB1 HER1 | RPKFRELIIEFSKMARDPQRyLVIQGDERMHLPsPtDsNFy |
| P00533 | Y998 | GPS6|EPSD|Sugiyama | EGFR ERBB ERBB1 HER1 | yLVIQGDERMHLPsPtDsNFyRALMDEEDMDDVVDADEyLI |
| P00558 | Y161 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | KAEPAKIEAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNL |
| P00966 | Y163 | Sugiyama | ASS1 ASS | APWRMPEFYNRFKGRNDLMEyAKQHGIPIPVtPKNPWSMDE |
| P02786 | Y402 | Sugiyama | TFRC | KEIKILNIFGVIKGFVEPDHyVVVGAQRDAWGPGAAKSGVG |
| P04080 | Y97 | Sugiyama | CSTB CST6 STFB | NKPLtLsNyQTNKAKHDELtyF___________________ |
| P04083 | Y21 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | ANXA1 ANX1 LPC1 | MAMVsEFLKQAWFIENEEQEyVQtVKssKGGPGsAVsPyPt |
| P04406 | Y314 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | tFDAGAGIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsK |
| P04406 | Y320 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsKE_____ |
| P04406 | Y94 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | ItIFQERDPsKIKWGDAGAEyVVEstGVFttMEKAGAHLQG |
| P04626 | Y1248 | SIGNOR|EPSD | ERBB2 HER2 MLN19 NEU NGL | PERGAPPstFKGtPtAENPEyLGLDVPV_____________ |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P04920 | Y73 | Sugiyama | SLC4A2 AE2 EPB3L1 HKB3 MPB3L | EAGsRGGEEPGRsYGEEDFEyHRQSSHHIHHPLSTHLPPDA |
| P05455 | Y104 | Sugiyama | SSB | EDKTKIRRsPsKPLPEVTDEyKNDVKNRsVYIKGFPtDAtL |
| P05787 | Y204 | Sugiyama | KRT8 CYK8 | NKRTEMENEFVLIKKDVDEAyMNKVELESRLEGLTDEINFL |
| P05787 | Y286 | Sugiyama | KRT8 CYK8 | QyEDIANRsRAEAEsMyQIKyEELQsLAGKHGDDLRRTKTE |
| P05997 | Y1311 | Sugiyama | COL5A2 | HPARTCDDLKLCHSAKQsGEyWIDPNQGSVEDAIKVYCNME |
| P06733 | S268 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | ASEFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyP |
| P06733 | Y189 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | MILPVGAANFREAMRIGAEVyHNLKNVIKEKyGKDAtNVGD |
| P06733 | Y270 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyPVV |
| P06733 | Y280 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | DFKsPDDPsRyIsPDQLADLyKsFIKDyPVVsIEDPFDQDD |
| P06733 | Y287 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | PsRyIsPDQLADLyKsFIKDyPVVsIEDPFDQDDWGAWQKF |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P07205 | Y161 | Sugiyama | PGK2 PGKB | KAEPDKIEAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNL |
| P07237 | Y94 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | GSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFFRNGDTASPK |
| P07355 | Y188 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | RKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVKRKGT |
| P07437 | Y106 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | RPDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKEAES |
| P07437 | Y50 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | IDPTGtyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEP |
| P07437 | Y51 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | DPTGtyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEPG |
| P07814 | Y1504 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | KPLCELQPGAKCVCGKNPAKyytLFGRsy____________ |
| P07814 | Y1505 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PLCELQPGAKCVCGKNPAKyytLFGRsy_____________ |
| P07814 | Y827 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | EIGQNIssNssAsILESKsLyDEVAAQGEVVRKLKAEKSPK |
| P07900 | Y160 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | SAYLVAEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGEPM |
| P07900 | Y197 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | GEPMGRGTKVILHLKEDQtEyLEERRIKEIVKKHSQFIGyP |
| P07900 | Y284 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEEEEKKDGDKKKKKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P07900 | Y309 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ELNKtKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHF |
| P07900 | Y313 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | tKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P07900 | Y492 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEMVsLKDYCTRMKENQKHIyyItGETKDQVANsAFVERLR |
| P07900 | Y493 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | EMVsLKDYCTRMKENQKHIyyItGETKDQVANsAFVERLRK |
| P07948 | Y32 | EPSD|PSP | LYN JTK8 | LsDDGVDLKTQPVRNTERTIyVRDPTSNKQQRPVPESQLLP |
| P08238 | Y155 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | SAYLVAEKVVVITKHNDDEQyAWEssAGGsFtVRADHGEPI |
| P08238 | Y192 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | GEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIGyP |
| P08238 | Y276 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P08238 | Y301 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHF |
| P08238 | Y305 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | tKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P08238 | Y472 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | sELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItGEsKE |
| P08238 | Y484 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVR |
| P08238 | Y485 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | EMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVRK |
| P09104 | Y44 | Sugiyama | ENO2 | LyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGKGVLK |
| P09211 | Y199 | GPS6|SIGNOR|EPSD|PSP | GSTP1 FAEES3 GST3 | AYVGRLsARPKLKAFLASPEyVNLPINGNGKQ_________ |
| P09211 | Y4 | GPS6|SIGNOR|EPSD|PSP | GSTP1 FAEES3 GST3 | _________________MPPyTVVyFPVRGRCAALRMLLAD |
| P09211 | Y8 | GPS6|SIGNOR|EPSD|PSP | GSTP1 FAEES3 GST3 | _____________MPPyTVVyFPVRGRCAALRMLLADQGQS |
| P09234 | T11 | Sugiyama | SNRPC | __________MPKFyCDyCDtyLtHDsPsVRKTHCSGRKHK |
| P09234 | Y12 | Sugiyama | SNRPC | _________MPKFyCDyCDtyLtHDsPsVRKTHCSGRKHKE |
| P09234 | Y8 | Sugiyama | SNRPC | _____________MPKFyCDyCDtyLtHDsPsVRKTHCSGR |
| P09496 | Y147 | Sugiyama | CLTA | NSRKQEAEWKEKAIKELEEWyARQDEQLQKTKANNRVADEA |
| P09651 | Y341 | Sugiyama | HNRNPA1 HNRPA1 | QSSNFGPMKGGNFGGRssGPyGGGGQyFAKPRNQGGyGGss |
| P09651 | Y347 | Sugiyama | HNRNPA1 HNRPA1 | PMKGGNFGGRssGPyGGGGQyFAKPRNQGGyGGssssssyG |
| P0C7P4 | Y100 | Sugiyama | UQCRFS1P1 UQCRFSL1 | NVPASVCYSHTDIKVPDFSEyRRLEVLDSTKSSRESTEARK |
| P0CG38 | Y1062 | Sugiyama | POTEI | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P0CG39 | Y1025 | Sugiyama | POTEJ | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P0CL80 | Y10 | Sugiyama | GAGE12F | ___________MSWRGRsTyyWPRPRRYVQPPEMIGPMRPE |
| P0CL80 | Y9 | Sugiyama | GAGE12F | ____________MSWRGRsTyyWPRPRRYVQPPEMIGPMRP |
| P0DP23 | Y100 | GPS6|SIGNOR|ELM|iPTMNet | CALM1 CALM CAM CAM1 | tDsEEEIREAFRVFDKDGNGyIsAAELRHVMTNLGEKLtDE |
| P0DP24 | Y100 | SIGNOR | CALM2 CAM2 CAMB | TDsEEEIREAFRVFDKDGNGyIsAAELRHVMTNLGEKLTDE |
| P0DP25 | Y100 | SIGNOR | CALM3 CALML2 CAM3 CAMC CAMIII | TDsEEEIREAFRVFDKDGNGyIsAAELRHVMTNLGEKLTDE |
| P0DSO3 | Y10 | Sugiyama | GAGE4 | ___________MSWRGRsTyyWPRPRRYVQPPEMIGPMRPE |
| P0DSO3 | Y9 | Sugiyama | GAGE4 | ____________MSWRGRsTyyWPRPRRYVQPPEMIGPMRP |
| P10412 | Y71 | Sugiyama | H1-4 H1F4 HIST1H1E | SKERsGVsLAALKKALAAAGyDVEKNNSRIKLGLKsLVsKG |
| P10809 | Y223 | Sugiyama | HSPD1 HSP60 | DGKtLNDELEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAy |
| P10809 | Y227 | Sugiyama | HSPD1 HSP60 | LNDELEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAyVLLs |
| P10809 | Y243 | Sugiyama | HSPD1 HSP60 | yIsPyFINtsKGQKCEFQDAyVLLsEKKIssIQsIVPALEI |
| P11047 | Y352 | Sugiyama | LAMC1 LAMB2 | tAEsASECLPCDCNGRsQECyFDPELyRSTGHGGHCTNCQD |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11142 | Y41 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P11142 | Y545 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | YKAEDEKQRDKVssKNsLEsyAFNMKATVEDEKLQGKINDE |
| P11171 | Y660 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | EPB41 E41P | TEDLIRMRKKKRERLDGENIyIRHsNLMLEDLDKsQEEIKK |
| P11233 | Y153 | Sugiyama | RALA RAL | DKRQVsVEEAKNRAEQWNVNyVETSAKTRANVDKVFFDLMR |
| P11940 | Y194 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | KSRKEREAELGARAKEFtNVyIKNFGEDMDDERLKDLFGKF |
| P12004 | Y211 | GPS6|SIGNOR|EPSD|PSP | PCNA | EEEAVTIEMNEPVQLTFALRyLNFFTKATPLSSTVTLSMSA |
| P12270 | Y140 | Sugiyama | TPR | LEAEKRDLIRTNERLsQELEyLTEDVKRLNEKLKESNTTKG |
| P12277 | Y125 | Sugiyama | CKB CKBB | EHKTDLNPDNLQGGDDLDPNyVLssRVRTGRSIRGFCLPPH |
| P12277 | Y39 | Sugiyama | CKB CKBB | EFPDLSAHNNHMAKVLtPELyAELRAKSTPSGFTLDDVIQT |
| P12814 | Y215 | Sugiyama | ACTN1 | KLRKDDPLTNLNTAFDVAEKyLDIPKMLDAEDIVGtARPDE |
| P12814 | Y842 | Sugiyama | ACTN1 | DTDTADQVMASFKILAGDKNyITMDELRRELPPDQAEyCIA |
| P12814 | Y859 | Sugiyama | ACTN1 | DKNyITMDELRRELPPDQAEyCIARMAPYTGPDSVPGALDY |
| P13639 | T582 | Sugiyama | EEF2 EF2 | EEDHACIPIKKSDPVVsyREtVsEEsNVLCLsKsPNKHNRL |
| P13639 | Y671 | Sugiyama | EEF2 EF2 | CFGPDGTGPNILTDITKGVQyLNEIKDSVVAGFQWATKEGA |
| P13667 | Y448 | Sugiyama | PDIA4 ERP70 ERP72 | RAATQFWRSKVLEVAKDFPEytFAIADEEDyAGEVKDLGLs |
| P13667 | Y458 | Sugiyama | PDIA4 ERP70 ERP72 | VLEVAKDFPEytFAIADEEDyAGEVKDLGLsEsGEDVNAAI |
| P13667 | Y565 | Sugiyama | PDIA4 ERP70 ERP72 | DVLIEFYAPWCGHCKQLEPVyNsLAKKYKGQKGLVIAKMDA |
| P13674 | Y141 | Sugiyama | P4HA1 P4HA | FPNDEDQVGAAKALLRLQDtyNLDTDtIsKGNLPGVKHKSF |
| P13674 | Y282 | Sugiyama | P4HA1 P4HA | ASDDQSDQKTTPKKKGVAVDyLPERQKyEMLCRGEGIKMTP |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P13929 | Y44 | Sugiyama | ENO3 | LHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGKGVLK |
| P13987 | Y86 | Sugiyama | CD59 MIC11 MIN1 MIN2 MIN3 MSK21 | KFEHCNFNDVtTRLRENELtyyCCKKDLCNFNEQLENGGTS |
| P14314 | Y106 | Sugiyama | PRKCSH G19P1 | yIPSNRVNDGVCDCCDGtDEyNsGVICENtCKEKGRKEREs |
| P14618 | Y148 | SIGNOR|EPSD|PSP | PKM OIP3 PK2 PK3 PKM2 | GtAEVELKKGATLKITLDNAyMEKCDENILWLDYKNICKVV |
| P14625 | Y401 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | VTFKSILFVPTSAPRGLFDEyGsKKSDYIKLYVRRVFITDD |
| P14625 | Y527 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | AKLLRFQssHHPtDItsLDQyVERMKEKQDKIyFMAGsSRK |
| P14649 | Y146 | Sugiyama | MYL6B MLC1SA | TFLPMLQAVAKNRGQGTyEDyLEGFRVFDKEGNGKVMGAEL |
| P14649 | Y86 | Sugiyama | MYL6B MLC1SA | LEEFKEAFELFDRVGDGKILysQCGDVMRALGQNPtNAEVL |
| P14927 | Y90 | Sugiyama | UQCRB UQBP | NLKHQILPKEQWTKyEEENFyLEPyLKEVIRERKEREEWAK |
| P15311 | Y146 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | EZR VIL2 | GSYAVQAKFGDYNKEVHKsGyLSsERLIPQRVMDQHKLTRD |
| P15311 | Y354 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | EZR VIL2 | EREKEQMMREKEELMLRLQDyEEKTKKAERELsEQIQRALQ |
| P15311 | Y424 | Sugiyama | EZR VIL2 | ERQAVDQIKsQEQLAAELAEytAKIALLEEARRRKEDEVEE |
| P15924 | Y56 | Sugiyama | DSP | GtsRMYYSRRGVITDQNsDGyCQtGtMsRHQNQNTIQELLQ |
| P15941 | Y1229 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | MUC1 PUM | yPtyHtHGRyVPPsstDRsPyEKVsAGNGGssLsytNPAVA |
| P16402 | Y72 | Sugiyama | H1-3 H1F3 HIST1H1D | SKERsGVsLAALKKALAAAGyDVEKNNSRIKLGLKsLVsKG |
| P16403 | Y71 | Sugiyama | H1-2 H1F2 HIST1H1C | SKERsGVsLAALKKALAAAGyDVEKNNSRIKLGLKsLVsKG |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17066 | Y43 | Sugiyama | HSPA6 HSP70B' | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P17676 | Y139 | Sugiyama | CEBPB TCF5 PP9092 | SDLFSDDYGGKNCKKPAEyGyVsLGRLGAAKGALHPGCFAP |
| P17812 | Y473 | Sugiyama | CTPS1 CTPS | RRtLFQTKNsVMRKLyGDADyLEERHRHRFEVNPVWKKCLE |
| P17980 | Y185 | Sugiyama | PSMC3 TBP1 | PtEyDsRVKAMEVDERPtEQysDIGGLDKQIQELVEAIVLP |
| P17980 | Y381 | Sugiyama | PSMC3 TBP1 | ARARIMQIHSRKMNVsPDVNyEELARCTDDFNGAQCKAVCV |
| P17987 | Y545 | Sugiyama | TCP1 CCT1 CCTA | LRIDDLIKLHPESKDDKHGsyEDAVHsGALND_________ |
| P18031 | Y66 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | PTPN1 PTP1B | yRDVsPFDHSRIKLHQEDNDyINAsLIKMEEAQRSYILTQG |
| P18206 | Y822 | Sugiyama | VCL | KAVAGNIsDPGLQKsFLDsGyRILGAVAKVREAFQPQEPDF |
| P18615 | Y133 | Sugiyama | NELFE RD RDBP | sIsADDDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGEEA |
| P18615 | Y170 | Sugiyama | NELFE RD RDBP | GEEAEGPGAGDGPPRsFDWGyEERSGAHSsAsPPRsRSRDR |
| P18615 | Y372 | Sugiyama | NELFE RD RDBP | NsPKGCHRDKRTQIVysDDVyKENLVDGF____________ |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P18669 | S134 | Sugiyama | PGAM1 PGAMA CDABP0006 | IWRRsyDVPPPPMEPDHPFysNIsKDRRyADLtEDQLPsCE |
| P18669 | Y142 | Sugiyama | PGAM1 PGAMA CDABP0006 | PPPPMEPDHPFysNIsKDRRyADLtEDQLPsCEsLKDtIAR |
| P18859 | Y67 | Sugiyama | ATP5PF ATP5A ATP5J ATPM | IREYKSKRQTsGGPVDAssEyQQELERELFKLKQMFGNADM |
| P19105 | Y142 | Sugiyama | MYL12A MLCB MRLC3 RLC | LRELLttMGDRFtDEEVDELyREAPIDKKGNFNyIEFtRIL |
| P19105 | Y155 | PSP|Sugiyama | MYL12A MLCB MRLC3 RLC | DEEVDELyREAPIDKKGNFNyIEFtRILKHGAKDKDD____ |
| P19174 | Y1253 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | PLCG1 PLC1 | sDASGQLFHGRAREGsFEsRyQQPFEDFRIsQEHLADHFDs |
| P19174 | Y472 | SIGNOR|iPTMNet|EPSD | PLCG1 PLC1 | PNQLKRKILIKHKKLAEGSAyEEVPTSMMYSENDISNSIKN |
| P19174 | Y771 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | PLCG1 PLC1 | KLRYPINEEALEKIGTAEPDyGALyEGRNPGFyVEANPMPT |
| P19174 | Y783 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | PLCG1 PLC1 | KIGTAEPDyGALyEGRNPGFyVEANPMPTFKCAVKALFDYK |
| P19338 | Y462 | Sugiyama | NCL | AEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWs |
| P19387 | Y208 | Sugiyama | POLR2C A-152E5.7 | PDNALRHTVYPKPEEWPKSEySELDEDESQAPYDPNGKPER |
| P20042 | Y176 | Sugiyama | EIF2S2 EIF2B | GIsFsNQtGPAWAGSERDytyEELLNRVFNIMREKNPDMVA |
| P20618 | Y150 | Sugiyama | PSMB1 PSC5 | FPYYVYNIIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSAS |
| P20810 | Y618 | Sugiyama | CAST | KAKAEHRDKLGERDDTIPPEyRHLLDDNGQDKPVKPPTKKS |
| P20936 | Y460 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | RASA1 GAP RASA | PVPMQDQEQVLNDTVDGKEIyNtIRRKTKDAFYKNIVKKGY |
| P21860 | Y1276 | SIGNOR | ERBB3 HER3 | PDEDyEyMNRQRDGGGPGGDyAAMGACPASEQGyEEMRAFQ |
| P21860 | Y1289 | SIGNOR | ERBB3 HER3 | GGGPGGDyAAMGACPASEQGyEEMRAFQGPGHQAPHVHyAR |
| P21980 | Y369 | Sugiyama | TGM2 | PGYEGWQALDPTPQEKsEGtyCCGPVPVRAIKEGDLstKyD |
| P22234 | Y22 | Sugiyama | PAICS ADE2 AIRC PAIS | AtAEVLNIGKKLYEGKtKEVyELLDsPGKVLLQsKDQItAG |
| P22314 | Y55 | Sugiyama | UBA1 A1S9T UBE1 | SVPTNGMAKNGsEADIDEGLysRQLyVLGHEAMKRLQTSSV |
| P22314 | Y560 | Sugiyama | UBA1 A1S9T UBE1 | NPHIRVTSHQNRVGPDtERIyDDDFFQNLDGVANALDNVDA |
| P22392 | Y151 | Sugiyama | NME2 NM23B | SLWFKPEELVDyKSCAHDWVyE___________________ |
| P22492 | Y75 | Sugiyama | H1-6 H1FT H1T HIST1H1T | SQERVGMSLVALKKALAAAGyDVEKNNSRIKLSLKSLVNKG |
| P22626 | Y336 | Sugiyama | HNRNPA2B1 HNRPA2B1 | MKsGNFGGsRNMGGPyGGGNyGPGGsGGsGGyGGRsRy___ |
| P22681 | Y371 | EPSD | CBL CBL2 RNF55 | GLCEPTPQDHIKVTQEQyELyCEMGSTFQLCKICAENDKDV |
| P22681 | Y700 | iPTMNet|EPSD | CBL CBL2 RNF55 | PLPVPKLPPGEQCEGEEDtEyMtPssRPLRPLDTsQSsRAC |
| P22681 | Y731 | iPTMNet|EPSD | CBL CBL2 RNF55 | LDTsQSsRACDCDQQIDSCTyEAMYNIQSQAPSITESSTFG |
| P22681 | Y774 | iPTMNet|EPSD | CBL CBL2 RNF55 | NLAAAHANTGPEESENEDDGyDVPKPPVPAVLARRtLsDIs |
| P23193 | Y126 | Sugiyama | TCEA1 GTF2S TFIIS | EsTSsGNVsNRKDETNARDTyVsSFPRAPstsDsVRLKCRE |
| P23246 | S491 | Sugiyama | SFPQ PSF | QKEREtPPRFAQHGtFEyEysQRWKsLDEMEKQQREQVEKN |
| P23246 | Y488 | Sugiyama | SFPQ PSF | PMYQKEREtPPRFAQHGtFEyEysQRWKsLDEMEKQQREQV |
| P23246 | Y490 | Sugiyama | SFPQ PSF | YQKEREtPPRFAQHGtFEyEysQRWKsLDEMEKQQREQVEK |
| P23434 | Y139 | Sugiyama | GCSH | EVTEINEALAENPGLVNKSCyEDGWLIKMtLsNPsELDELM |
| P23526 | Y193 | Sugiyama | AHCY SAHH | LKVPAINVNDsVtKsKFDNLyGCRESLIDGIKRATDVMIAG |
| P23528 | T70 | Sugiyama | CFL1 CFL | EEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAtyE |
| P23528 | T88 | Sugiyama | CFL1 CFL | yAtFVKMLPDKDCRyALyDAtyEtKESKKEDLVFIFWAPES |
| P23528 | Y140 | Sugiyama | CFL1 CFL | SKDAIKKKLtGIKHELQANCyEEVKDRCTLAEKLGGsAVIs |
| P23528 | Y68 | Sugiyama | CFL1 CFL | ILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAt |
| P23528 | Y82 | Sugiyama | CFL1 CFL | QtVDDPyAtFVKMLPDKDCRyALyDAtyEtKESKKEDLVFI |
| P23528 | Y89 | Sugiyama | CFL1 CFL | AtFVKMLPDKDCRyALyDAtyEtKESKKEDLVFIFWAPESA |
| P23588 | Y211 | Sugiyama | EIF4B | DsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYRDRYDsD |
| P23588 | Y609 | Sugiyama | EIF4B | sASKyAALsVDGEDENEGEDyAE__________________ |
| P24534 | Y18 | Sugiyama | EEF1B2 EEF1B EF1B | ___MGFGDLKsPAGLQVLNDyLADKSYIEGYVPsQADVAVF |
| P24752 | Y214 | Sugiyama | ACAT1 ACAT MAT | GsCAENTAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNE |
| P24844 | Y143 | GPS6|ELM|iPTMNet|EPSD | MYL9 MLC2 MRLC1 MYRL2 | LRELLttMGDRFtDEEVDEMyREAPIDKKGNFNyVEFTRIL |
| P24844 | Y156 | GPS6|ELM|iPTMNet|EPSD | MYL9 MLC2 MRLC1 MYRL2 | DEEVDEMyREAPIDKKGNFNyVEFTRILKHGAKDKDD____ |
| P25205 | Y19 | Sugiyama | MCM3 | __MAGtVVLDDVELREAQRDyLDFLDDEEDQGIyQsKVREL |
| P25205 | Y708 | Sugiyama | MCM3 | KRKRRKTRQPDAKDGDsyDPyDFsDtEEEMPQVHtPKTADs |
| P25398 | Y127 | Sugiyama | RPS12 | sCVVVKDYGKESQAKDVIEEyFKCKK_______________ |
| P25685 | Y5 | Sugiyama | DNAJB1 DNAJ1 HDJ1 HSPF1 | ________________MGKDyyQTLGLARGAsDEEIKRAYR |
| P25685 | Y52 | Sugiyama | DNAJB1 DNAJ1 HDJ1 HSPF1 | HPDKNKEPGAEEKFKEIAEAyDVLSDPRKREIFDRYGEEGL |
| P25685 | Y6 | Sugiyama | DNAJB1 DNAJ1 HDJ1 HSPF1 | _______________MGKDyyQTLGLARGAsDEEIKRAYRR |
| P26196 | Y469 | Sugiyama | DDX6 HLR2 RCK | IEEQLGTEIKPIPsNIDKSLyVAEyHsEPVEDEKP______ |
| P26196 | Y473 | Sugiyama | DDX6 HLR2 RCK | LGTEIKPIPsNIDKSLyVAEyHsEPVEDEKP__________ |
| P26599 | Y127 | Sugiyama | PTBP1 PTB | ANTMVNYYTSVTPVLRGQPIyIQFsNHKELKtDSSPNQARA |
| P27348 | Y149 | Sugiyama | YWHAQ | LAEVACGDDRKQtIDNsQGAyQEAFDIsKKEMQPTHPIRLG |
| P27348 | Y48 | Sugiyama | YWHAQ | AVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSIEQK |
| P27540 | Y561 | Sugiyama | ARNT BHLHE2 | PLEKSDGLFAQDRDPRFsEIyHNINADQSKGISSSTVPATQ |
| P27695 | Y128 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | LQELPGLSHQYWSAPsDKEGysGVGLLsRQCPLKVsyGIGD |
| P27695 | Y45 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | KSKTAAKKNDKEAAGEGPALyEDPPDQKtsPsGKPAtLKIC |
| P27797 | Y109 | Sugiyama | CALR CRTC | QTLVVQFTVKHEQNIDCGGGyVKLFPNSLDQTDMHGDSEYN |
| P27797 | Y338 | Sugiyama | CALR CRTC | LWQVKSGTIFDNFLITNDEAyAEEFGNETWGVtKAAEKQMK |
| P27816 | Y47 | Sugiyama | MAP4 | AtLEAEAFDDVVGETVGKTDyIPLLDVDEKtGNsESKKKPC |
| P27824 | Y70 | Sugiyama | CANX | TAPPSSPKVTYKAPVPtGEVyFADsFDRGTLSGWILSKAKK |
| P28062 | Y271 | Sugiyama | PSMB8 LMP7 PSMB5i RING10 Y2 | MKEDGWVKVEsTDVSDLLHQyREANQ_______________ |
| P29353 | Y427 | Sugiyama | SHC1 SHC SHCA | RKQMPPPPPCPGRELFDDPsyVNVQNLDKARQAVGGAGPPN |
| P29401 | Y481 | Sugiyama | TKT | AANTKGICFIRTsRPENAIIyNNNEDFQVGQAKVVLKSKDD |
| P29692 | Y26 | Sugiyama | EEF1D EF1D | LAHEKIWFDKFKYDDAERRFyEQMNGPVAGAsRQENGAsVI |
| P30043 | Y205 | Sugiyama | BLVRB FLR SCAN | MLRCLttDEyDGHstyPsHQyQ___________________ |
| P30085 | Y49 | Sugiyama | CMPK1 CMK CMPK UCK UMK UMPK | ytHLSAGELLRDERKNPDsQyGELIEKYIKEGKIVPVEITI |
| P30086 | T65 | Sugiyama | PEBP1 PBP PEBP | QVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREWH |
| P30086 | Y106 | Sugiyama | PEBP1 PBP PEBP | HFLVVNMKGNDIssGtVLsDyVGsGPPKGtGLHRyVWLVyE |
| P30086 | Y176 | Sugiyama | PEBP1 PBP PEBP | KKyELRAPVAGtCyQAEWDDyVPKLyEQLsGK_________ |
| P30086 | Y64 | Sugiyama | PEBP1 PBP PEBP | tQVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREW |
| P30101 | Y115 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | yGVsGyPtLKIFRDGEEAGAyDGPRtADGIVsHLKKQAGPA |
| P30101 | Y356 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | FVMQEEFsRDGKALERFLQDyFDGNLKRyLKsEPIPESNDG |
| P30101 | Y67 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LMLVEFFAPWCGHCKRLAPEyEAAAtRLKGIVPLAKVDCTA |
| P30533 | Y246 | Sugiyama | LRPAP1 A2MRAP | EKLRsINQGLDRLRRVsHQGystEAEFEEPRVIDLWDLAQS |
| P30622 | Y108 | Sugiyama | CLIP1 CYLN1 RSN | AGIVLDEPIGKNDGSVAGVRyFQCEPLKGIFTRPSKLTRKV |
| P31153 | Y242 | Sugiyama | MAT2A AMS2 MATA2 | LKEKVIKAVVPAKyLDEDtIyHLQPsGRFVIGGPQGDAGLt |
| P31327 | Y1450 | Sugiyama | CPS1 | GsIDLVINLPNNNTKFVHDNyVIRRTAVDSGIPLLTNFQVT |
| P31943 | Y266 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | yNGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGstFQst |
| P31946 | S147 | Sugiyama | YWHAB | YFRyLsEVAsGDNKQTtVsNsQQAyQEAFEIsKKEMQPTHP |
| P31946 | Y151 | Sugiyama | YWHAB | LsEVAsGDNKQTtVsNsQQAyQEAFEIsKKEMQPTHPIRLG |
| P31946 | Y21 | Sugiyama | YWHAB | MTMDKsELVQKAKLAEQAERyDDMAAAMKAVtEQGHELsNE |
| P31946 | Y50 | Sugiyama | YWHAB | AVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P31947 | Y151 | Sugiyama | SFN HME1 | LAEVATGDDKKRIIDSARsAyQEAMDISKKEMPPTNPIRLG |
| P31947 | Y48 | Sugiyama | SFN HME1 | GAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsIEQK |
| P31948 | Y354 | Sugiyama | STIP1 | DVLKKCQQAEKILKEQERLAyINPDLALEEKNKGNECFQKG |
| P31948 | Y41 | Sugiyama | STIP1 | DDALQCysEAIKLDPHNHVLysNRsAAyAKKGDYQKAyEDG |
| P32119 | Y115 | Sugiyama | PRDX2 NKEFB TDPX1 | GLGPLNIPLLADVTRRLsEDyGVLKTDEGIAYRGLFIIDGK |
| P32929 | S61 | Sugiyama | CTH | ISLSTTFKQGAPGQHsGFEysRsGNPTRNCLEKAVAALDGA |
| P32969 | Y180 | Sugiyama | RPL9 OK/SW-cl.103; RPL9P7; RPL9P8; RPL9P9 | LIQQATTVKNKDIRKFLDGIyVsEKGtVQQADE________ |
| P33176 | Y516 | Sugiyama | KIF5B KNS KNS1 | EELAVNyDQKSQEVEDKTKEyELLSDELNQKsATLAsIDAE |
| P33316 | Y167 | Sugiyama | DUT | PPMEKAVVKTDIQIALPsGCyGRVAPRSGLAAKHFIDVGAG |
| P34896 | T178 | Sugiyama | SHMT1 | KKISATSIFFESMPYKVNPDtGyINyDQLEENARLFHPKLI |
| P34896 | Y180 | Sugiyama | SHMT1 | ISATSIFFESMPYKVNPDtGyINyDQLEENARLFHPKLIIA |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P34931 | Y43 | Sugiyama | HSPA1L | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P34932 | Y30 | Sugiyama | HSPA4 APG2 HSPH2 | FQSCYVAVARAGGIETIANEysDRCtPACIsFGPKNRSIGA |
| P34932 | Y336 | Sugiyama | HSPA4 APG2 HSPH2 | RVEPPLRSVLEQTKLKKEDIyAVEIVGGATRIPAVKEKISK |
| P34932 | Y597 | Sugiyama | HSPA4 APG2 HSPH2 | VDLPIENQLLWQIDREMLNLyIENEGKMIMQDKLEKERNDA |
| P34932 | Y624 | Sugiyama | HSPA4 APG2 HSPH2 | MIMQDKLEKERNDAKNAVEEyVyEMRDKLSGEYEKFVSEDD |
| P34932 | Y626 | Sugiyama | HSPA4 APG2 HSPH2 | MQDKLEKERNDAKNAVEEyVyEMRDKLSGEYEKFVSEDDRN |
| P35222 | Y142 | EPSD|PSP | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | VQRLAEPSQMLKHAVVNLINyQDDAELATRAIPELTKLLND |
| P35222 | Y654 | EPSD|PSP | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | EGATAPLTELLHsRNEGVAtyAAAVLFRMSEDKPQDyKKRL |
| P35579 | Y9 | Sugiyama | MYH9 | ____________MAQQAADKyLyVDKNFINNPLAQADWAAK |
| P35580 | Y13 | Sugiyama | MYH10 | ________MAQRTGLEDPERyLFVDRAVIYNPATQADWTAK |
| P35637 | Y468 | Sugiyama | FUS TLS | KAPKPDGPGGGPGGsHMGGNyGDDRRGGRGGYDRGGYRGRG |
| P36871 | Y476 | Sugiyama | PGM1 | GKQFSANDKVYtVEKADNFEysDPVDGsIsRNQGLRLIFTD |
| P37231 | Y102 | SIGNOR | PPARG NR1C3 | PFTRTDPVVADYKYDLKLQEyQSAIKVEPAsPPYYSEKTQL |
| P37802 | Y192 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NVIGLQMGtNRGAsQAGMtGyGMPRQIL_____________ |
| P37840 | Y39 | Sugiyama | SNCA NACP PARK1 | AEKTKQGVAEAAGKTKEGVLyVGsKTKEGVVHGVATVAEKT |
| P38646 | Y118 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | ERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIK |
| P39019 | Y48 | Sugiyama | RPS19 | LKVPEWVDtVKLAKHKELAPyDENWFytRAAstARHLYLRG |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P39687 | Y144 | Sugiyama | ANP32A C15orf1 LANP MAPM PHAP1 | EVtNLNDyRENVFKLLPQLtyLDGyDRDDKEAPDsDAEGYV |
| P39687 | Y148 | Sugiyama | ANP32A C15orf1 LANP MAPM PHAP1 | LNDyRENVFKLLPQLtyLDGyDRDDKEAPDsDAEGYVEGLD |
| P40261 | Y11 | Sugiyama | NNMT | __________MESGFTSKDTyLSHFNPRDYLEKYYKFGSRH |
| P40818 | Y717 | EPSD|PSP | USP8 KIAA0055 UBPY | KAKPQIPAERDREPSKLKRsyssPDItQAIQEEEKRKPTVt |
| P40818 | Y810 | EPSD|PSP | USP8 KIAA0055 UBPY | SILQCLCNAPHLADYFNRNCyQDDINRSNLLGHKGEVAEEF |
| P41212 | Y447 | Sugiyama | ETV6 TEL TEL1 | MSGRTDRLEHLEsQELDEQIyQEDEC_______________ |
| P41567 | Y30 | Sugiyama | EIF1 SUI1 | FDPFADAsKGDDLLPAGTEDyIHIRIQQRNGRKtLttVQGI |
| P42224 | Y170 | Sugiyama | STAT1 | KDKVMCIEHEIKsLEDLQDEyDFKCKTLQNREHETNGVAKS |
| P42224 | Y701 | iPTMNet|EPSD | STAT1 | YSRPKEAPEPMELDGPKGtGyIKtELIsVsEVHPSRLQttD |
| P42566 | Y849 | GPS6|SIGNOR|iPTMNet|EPSD | EPS15 AF1P | SATTTTNKEADPSNFANFsAyPsEEDMIEWAKRESEREEEQ |
| P42765 | Y198 | Sugiyama | ACAA2 | ECDKyALQSQQRWKAANDAGyFNDEMAPIEVKTKKGKQTMQ |
| P43243 | Y202 | Sugiyama | MATR3 KIAA0723 | RHFRRDsFDDRGPsLNPVLDyDHGsRsQEsGyyDRMDyEDD |
| P43243 | Y773 | Sugiyama | MATR3 KIAA0723 | DPNKDtsENADGQsDENKDDyTIPDEYRIGPYQPNVPVGID |
| P46108 | Y221 | SIGNOR|iPTMNet|EPSD | CRK | IGGNQEGSHPQPLGGPEPGPyAQPSVNTPLPNLQNGPIyAR |
| P46778 | T29 | Sugiyama | RPL21 | RGTRYMFSRPFRKHGVVPLAtyMRIYKKGDIVDIKGMGTVQ |
| P46778 | Y156 | Sugiyama | RPL21 | REAHFVRTNGKEPELLEPIPyEFMA________________ |
| P46778 | Y30 | Sugiyama | RPL21 | GTRYMFSRPFRKHGVVPLAtyMRIYKKGDIVDIKGMGTVQK |
| P46937 | Y407 | Sugiyama | YAP1 YAP65 | NsGtyHsRDEstDsGLsMssysVPRtPDDFLNsVDEMDTGD |
| P47224 | Y114 | Sugiyama | RABIF MSS4 RASGRF3 | CADCEIGPIGWHCLDDKNSFyVALERVSHE___________ |
| P47756 | Y59 | Sugiyama | CAPZB | LLSSVDQPLKIARDKVVGKDyLLCDyNRDGDSyRsPWSNKy |
| P47914 | Y98 | Sugiyama | RPL29 | PKEVKPKIPKGVSRKLDRLAyIAHPKLGKRARARIAKGLRL |
| P47985 | Y91 | Sugiyama | UQCRFS1 | NVPASVCYSHTDIKVPDFSEyRRLEVLDstKSSRESSEARK |
| P48050 | Y234 | SIGNOR|EPSD|PSP | KCNJ4 IRK3 | IVEAHVRAQLIKPYMTQEGEyLPLDQRDLNVGYDIGLDRIF |
| P48431 | Y277 | PSP | SOX2 | SSSHSRAPCQAGDLRDMISMyLPGAEVPEPAAPSRLHMSQH |
| P48643 | Y274 | Sugiyama | CCT5 CCTE KIAA0098 | PFEPPKPKTKHKLDVtsVEDyKALQKYEKEKFEEMIQQIKE |
| P48681 | Y928 | Sugiyama | NES Nbla00170 | EVDKEsQRNLEEEENLGKGEyQEsLRsLEEEGQELPQsADV |
| P48739 | Y154 | Sugiyama | PITPNB | KTVEIVHIDIADRSQVEPADyKADEDPALFQsVKtKRGPLG |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P48741 | Y43 | Sugiyama | HSPA7 HSP70B | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P49327 | Y2462 | Sugiyama | FASN FAS | NVMLLRAKtGGAyGEDLGADyNLsQVCDGKVsVHVIEGDHR |
| P49327 | Y277 | Sugiyama | FASN FAS | KEQGVtFPsGDIQEQLIRSLyQsAGVAPEsFEyIEAHGtGT |
| P49327 | Y289 | Sugiyama | FASN FAS | QEQLIRSLyQsAGVAPEsFEyIEAHGtGTKVGDPQELNGIt |
| P49736 | Y137 | Sugiyama | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | MRQRDREAGRGLGRMRRGLLyDsDEEDEERPARKRRQVERA |
| P49736 | Y234 | Sugiyama | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | VFKERIsDMCKENREsLVVNyEDLAAREHVLAYFLPEAPAE |
| P50395 | Y197 | Sugiyama | GDI2 RABGDIB | LGQDVIDFTGHALALYRtDDyLDQPCyEtINRIKLYsEsLA |
| P50542 | Y163 | Sugiyama | PEX5 PXR1 | EFISEVTDPLSVSPARWAEEyLEQsEEKLWLGEPEGTATDR |
| P50990 | Y30 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | GFAQMLKEGAKHFsGLEEAVyRNIQACKELAQTTRTAYGPN |
| P51116 | Y614 | Sugiyama | FXR2 FMR1L2 | RGNRtDGsIsGDRQPVtVADyIsRAEsQsRQRPPLERTKPs |
| P51692 | Y699 | GPS6|SIGNOR|iPTMNet|EPSD | STAT5B | ySKyytPVPCESATAKAVDGyVKPQIKQVVPEFVNASADAG |
| P51692 | Y725 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | STAT5B | KQVVPEFVNASADAGGGSATyMDQAPsPAVCPQAHyNMyPQ |
| P51692 | Y740 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | STAT5B | GGSATyMDQAPsPAVCPQAHyNMyPQNPDSVLDTDGDFDLE |
| P51692 | Y743 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | STAT5B | ATyMDQAPsPAVCPQAHyNMyPQNPDSVLDTDGDFDLEDTM |
| P51965 | Y77 | Sugiyama | UBE2E1 UBCH6 | ADITLDPPPNCSAGPKGDNIyEWRSTILGPPGSVYEGGVFF |
| P52272 | Y681 | Sugiyama | HNRNPM HNRPM NAGR1 | PFDFTWKMLKDKFNECGHVLyADIKMENGKSKGCGVVKFEs |
| P52298 | Y14 | Sugiyama | NCBP2 CBP20 PIG55 | _______MSGGLLKALRsDsyVELSQYRDQHFRGDNEEQEK |
| P52565 | Y156 | Sugiyama | ARHGDIA GDIA1 | GVKIDKtDyMVGsYGPRAEEyEFLtPVEEAPKGMLARGsYs |
| P52597 | Y266 | Sugiyama | HNRNPF HNRPF | ySGLSDGYGFTTDLFGRDLsyCLsGMyDHRYGDsEFtVQsT |
| P52597 | Y82 | Sugiyama | HNRNPF HNRPF | GsEDDVKMALKKDRESMGHRyIEVFKSHRTEMDWVLKHsGP |
| P52735 | Y142 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | VAV2 | QNKGIRPFPSEETTENDDDVyRSLEELADEHDLGEDIyDCV |
| P52735 | Y159 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | VAV2 | DDVyRSLEELADEHDLGEDIyDCVPCEDGGDDIyEDIIKVE |
| P52735 | Y172 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | VAV2 | HDLGEDIyDCVPCEDGGDDIyEDIIKVEVQQPMIRYMQKMG |
| P52948 | Y208 | Sugiyama | NUP98 ADAR2 | CITAMKEYESKSLEELRLEDyQANRKGPQNQVGAGTTTGLF |
| P52948 | Y627 | Sugiyama | NUP98 ADAR2 | NsNLFsPVNRDsENLAsPsEyPENGERFsFLSKPVDENHQQ |
| P53611 | Y26 | Sugiyama | RABGGTB GGTB | KDVIIKsDAPDTLLLEKHADyIASYGSKKDDYEYCMSEYLR |
| P53634 | Y438 | Sugiyama | CTSC CPPI | SGMDYWIVKNsWGtGWGENGyFRIRRGtDECAIEsIAVAAt |
| P54105 | Y38 | Sugiyama | CLNS1A CLCI ICLN | RQQPDTEAVLNGKGLGtGtLyIAEsRLSWLDGsGLGFSLEY |
| P54577 | Y388 | Sugiyama | YARS1 YARS | LDIRVGKIITVEKHPDADsLyVEKIDVGEAEPRTVVSGLVQ |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P54652 | Y42 | Sugiyama | HSPA2 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P55060 | Y369 | Sugiyama | CSE1L CAS XPO2 | VPNMEFRAADEEAFEDNsEEyIRRDLEGsDIDTRRRAACDL |
| P55196 | Y1230 | Sugiyama | AFDN AF6 MLLT4 | QtPPPRPEAyPIPtQtYtREyFtFPAsKsQDRMAPPQNQWP |
| P55196 | Y1497 | Sugiyama | AFDN AF6 MLLT4 | VIRELQPQQQPRTIERRDLQyItVsKEELssGDsLsPDPWK |
| P55209 | Y66 | Sugiyama | NAP1L1 NRP | PQILAALQERLDGLVEtPtGyIEsLPRVVKRRVNALKNLQV |
| P55795 | Y266 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | YGGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGssFQst |
| P60174 | Y209 | Sugiyama | TPI1 TPI | LRGWLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDG |
| P60174 | Y48 | Sugiyama | TPI1 TPI | tLNAAKVPADtEVVCAPPtAyIDFARQKLDPKIAVAAQNCy |
| P60660 | Y29 | Sugiyama | MYL6 | TAEFKEAFQLFDRtGDGKILysQCGDVMRALGQNPtNAEVL |
| P60660 | Y86 | Sugiyama | MYL6 | DFEHFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMG |
| P60660 | Y89 | Sugiyama | MYL6 | HFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMGAEI |
| P60709 | Y198 | Sugiyama | ACTB | LDLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCy |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P60709 | Y362 | Sugiyama | ACTB | GGsILAsLstFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P60842 | Y70 | Sugiyama | EIF4A1 DDX2A EIF4A | yGFEKPsAIQQRAILPCIKGyDVIAQAQsGtGKTATFAISI |
| P61024 | S9 | Sugiyama | CKS1B CKS1 PNAS-143 PNAS-16 | ____________MSHKQIyysDKyDDEEFEyRHVMLPKDIA |
| P61024 | Y19 | Sugiyama | CKS1B CKS1 PNAS-143 PNAS-16 | __MSHKQIyysDKyDDEEFEyRHVMLPKDIAKLVPKTHLMs |
| P61024 | Y7 | Sugiyama | CKS1B CKS1 PNAS-143 PNAS-16 | ______________MSHKQIyysDKyDDEEFEyRHVMLPKD |
| P61247 | Y256 | Sugiyama | RPS3A FTE1 MFTL | sssGKAtGDEtGAKVERADGyEPPVQEsV____________ |
| P61353 | Y85 | Sugiyama | RPL27 | RSKIKSFVKVyNyNHLMPtRysVDIPLDKtVVNKDVFRDPA |
| P61604 | Y100 | Sugiyama | HSPE1 | KVVLDDKDyFLFRDGDILGKyVD__________________ |
| P61604 | Y88 | Sugiyama | HSPE1 | GDKVLLPEyGGtKVVLDDKDyFLFRDGDILGKyVD______ |
| P61925 | Y8 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | PKIA PRKACN1 | _____________MTDVETTyADFIASGRTGRRNAIHDILV |
| P61981 | Y20 | Sugiyama | YWHAG | _MVDREQLVQKARLAEQAERyDDMAAAMKNVtELNEPLsNE |
| P61981 | Y49 | Sugiyama | YWHAG | NVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P62081 | Y177 | Sugiyama | RPS7 | HLDKAQQNNVEHKVEtFsGVyKKLTGKDVNFEFPEFQL___ |
| P62191 | Y184 | Sugiyama | PSMC1 | MDDTDPLVTVMKVEKAPQETyADIGGLDNQIQEIKESVELP |
| P62191 | Y439 | Sugiyama | PSMC1 | FKKSKENVLyKKQEGtPEGLyL___________________ |
| P62258 | Y152 | Sugiyama | YWHAE | LAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHPIRLG |
| P62258 | Y214 | Sugiyama | YWHAE | LAKAAFDDAIAELDtLsEEsyKDstLIMQLLRDNLtLWtsD |
| P62258 | Y49 | Sugiyama | YWHAE | KVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssIEQK |
| P62263 | S70 | Sugiyama | RPS14 PRO2640 | KETICRVTGGMKVKADRDEssPyAAMLAAQDVAQRCKELGI |
| P62269 | Y95 | Sugiyama | RPS18 D6S218E | RQYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLK |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62280 | Y55 | Sugiyama | RPS11 | RYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILsG |
| P62312 | Y72 | Sugiyama | LSM6 | VNGQLKNKyGDAFIRGNNVLyIstQKRRM____________ |
| P62495 | Y345 | Sugiyama | ETF1 ERF1 RF1 SUP45L1 | NLDIMRYVLHCQGTEEEKILyLTPEQEKDKSHFTDKETGQE |
| P62633 | Y120 | Sugiyama | CNBP RNF163 ZNF9 | NCGKPGHLARDCDHADEQKCysCGEFGHIQKDCTKVKCYRC |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62750 | Y144 | Sugiyama | RPL23A | VNtLIRPDGEKKAYVRLAPDyDALDVANKIGII________ |
| P62805 | Y52 | Sugiyama | H4C1 H4/A H4FA HIST1H4A; H4C2 H4/I H4FI HIST1H4B; H4C3 H4/G H4FG HIST1H4C; H4C4 H4/B H4FB HIST1H4D; H4C5 H4/J H4FJ HIST1H4E; H4C6 H4/C H4FC HIST1H4F; H4C8 H4/H H4FH HIST1H4H; H4C9 H4/M H4FM HIST1H4I; H4C11 H4/E H4FE HIST1H4J; H4C12 H4/D H4FD HIST1H4K; H4C13 H4/K H4FK HIST1H4L; H4C14 H4/N H4F2 H4FN HIST2H4 HIST2H4A; H4C15 H4/O H4FO HIST2H4B; H4C16 H4-16 HIST4H4 | KPAIRRLARRGGVKRIsGLIyEETRGVLKVFLENVIRDAVt |
| P62826 | Y146 | Sugiyama | RAN ARA24 OK/SW-cl.81 | IKDRKVKAKsIVFHRKKNLQyyDIsAKSNyNFEKPFLWLAR |
| P62826 | Y147 | Sugiyama | RAN ARA24 OK/SW-cl.81 | KDRKVKAKsIVFHRKKNLQyyDIsAKSNyNFEKPFLWLARK |
| P62899 | Y25 | Sugiyama | RPL31 | KKGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRA |
| P62906 | T9 | Sugiyama | RPL10A NEDD6 | ____________MSSKVsRDtLyEAVREVLHGNQRKRRKFL |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62937 | Y79 | Sugiyama | PPIA CYPA | GFMCQGGDFtRHNGTGGKsIyGEKFEDENFILKHtGPGILs |
| P62942 | Y27 | Sugiyama | FKBP1A FKBP1 FKBP12 | tIsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRDRNKPF |
| P62979 | Y148 | Sugiyama | RPS27A UBA80 UBCEP1 | AGVFMAsHFDRHyCGKCCLtyCFNKPEDK____________ |
| P62993 | Y209 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | GRB2 ASH | SDPNWWKGACHGQTGMFPRNyVTPVNRNV____________ |
| P63096 | Y154 | SIGNOR|PSP | GNAI1 | SGVQACFNRSREYQLNDSAAyyLNDLDRIAQPNYIPTQQDV |
| P63096 | Y155 | SIGNOR|PSP | GNAI1 | GVQACFNRSREYQLNDSAAyyLNDLDRIAQPNYIPTQQDVL |
| P63096 | Y320 | SIGNOR|PSP | GNAI1 | AAYIQCQFEDLNKRKDTKEIytHFTCATDTKNVQFVFDAVT |
| P63104 | Y149 | Sugiyama | YWHAZ | LAEVAAGDDKKGIVDQsQQAyQEAFEIsKKEMQPTHPIRLG |
| P63104 | Y48 | Sugiyama | YWHAZ | sVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssIEQK |
| P63173 | Y41 | Sugiyama | RPL38 | KSVKIKKNKDNVKFKVRCSRyLytLVItDKEKAEKLKQSLP |
| P63173 | Y43 | Sugiyama | RPL38 | VKIKKNKDNVKFKVRCSRyLytLVItDKEKAEKLKQSLPPG |
| P63220 | Y53 | Sugiyama | RPS21 | QMNVAEVDKVTGRFNGQFKtyAICGAIRRMGEsDDsILRLA |
| P63261 | Y198 | Sugiyama | ACTG1 ACTG | LDLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCy |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63261 | Y362 | Sugiyama | ACTG1 ACTG | GGsILAsLstFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P67775 | Y307 | EPSD|PSP | PPP2CA | LQFDPAPRRGEPHVTRRtPDyFL__________________ |
| P67809 | S209 | Sugiyama | YBX1 NSEP1 YB1 | RRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGEQ |
| P67809 | Y162 | Sugiyama | YBX1 NSEP1 YB1 | RNHYRRYPRRRGPPRNyQQNyQNsEsGEKNEGsEsAPEGQA |
| P67809 | Y208 | Sugiyama | YBX1 NSEP1 YB1 | yRRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGE |
| P67809 | Y72 | Sugiyama | YBX1 NSEP1 YB1 | KKVIATKVLGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIK |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68104 | Y29 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68363 | S439 | Sugiyama | TUBA1B | SEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy________ |
| P68363 | Y432 | Sugiyama | TUBA1B | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| P78316 | Y119 | Sugiyama | NOP14 C4orf9 NOL14 RES4-25 | EKMMKRFALEQQRHHEKKSIyNLNEDEELTHyGQsLADIEK |
| P78316 | Y130 | Sugiyama | NOP14 C4orf9 NOL14 RES4-25 | QRHHEKKSIyNLNEDEELTHyGQsLADIEKHNDIVDsDsDA |
| P78318 | Y277 | Sugiyama | IGBP1 IBP1 | AGYPSLPTMTVSDWYEQHRKyGALPDQGIAKAAPEEFRKAA |
| P78527 | T2609 | PSP | PRKDC HYRC HYRC1 | YTIDSDWRFRSTVLtPMFVEtQAsQGtLQtRtQEGsLSARW |
| P80303 | Y389 | Sugiyama | NUCB2 NEFA | QKQKEELQRQHDQLEAQKLEyHQVIQQMEQKKLQQGIPPSG |
| P98082 | Y38 | Sugiyama | DAB2 DOC2 | AAPKAPsKKEKKKGPEKTDEyLLARFKGDGVKYKAKLIGID |
| P98175 | Y694 | Sugiyama | RBM10 DXS8237E GPATC9 GPATCH9 KIAA0122 | QPISSLRDDERREsAtADAGyAILEKKGALAERQHTsMDLP |
| P98179 | Y117 | Sugiyama | RBM3 RNPL | HGRGRSYSRGGGDQGYGSGRyyDsRPGGyGyGyGRSRDYNG |
| P98179 | Y125 | Sugiyama | RBM3 RNPL | RGGGDQGYGSGRyyDsRPGGyGyGyGRSRDYNGRNQGGYDR |
| P98179 | Y129 | Sugiyama | RBM3 RNPL | DQGYGSGRyyDsRPGGyGyGyGRSRDYNGRNQGGYDRysGG |
| Q00169 | Y140 | Sugiyama | PITPNA PITPN | GTQENVHKLEPEAWKHVEAVyIDIADRSQVLSKDYKAEEDP |
| Q00534 | Y13 | Sugiyama | CDK6 CDKN6 | ________MEKDGLCRADQQyECVAEIGEGAyGKVFKARDL |
| Q00839 | Y257 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | QKGGDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVE |
| Q00839 | Y260 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | GDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVEEED |
| Q01105 | S133 | Sugiyama | SET | DEEALHYLTRVEVtEFEDIKsGyRIDFyFDENPyFENKVLS |
| Q01105 | Y135 | Sugiyama | SET | EALHYLTRVEVtEFEDIKsGyRIDFyFDENPyFENKVLSKE |
| Q01105 | Y140 | Sugiyama | SET | LTRVEVtEFEDIKsGyRIDFyFDENPyFENKVLSKEFHLNE |
| Q01105 | Y146 | Sugiyama | SET | tEFEDIKsGyRIDFyFDENPyFENKVLSKEFHLNEsGDPss |
| Q01130 | Y44 | Sugiyama | SRSF2 SFRS2 | RtsPDtLRRVFEKYGRVGDVyIPRDRYTKESRGFAFVRFHD |
| Q01813 | Y64 | PSP | PFKP PFKF | RAVVRMGIYVGAKVYFIYEGyQGMVDGGSNIAEADWESVSS |
| Q01844 | Y278 | Sugiyama | EWSR1 EWS | SSSYGQQSsFRQDHPssMGVyGQESGGFSGPGENRSMSGPD |
| Q01844 | Y417 | Sugiyama | EWSR1 EWS | MIHIYLDKETGKPKGDATVSyEDPPtAKAAVEWFDGKDFQG |
| Q02539 | Y74 | Sugiyama | H1-1 H1F1 HIST1H1A | SKERGGVSLAALKKALAAAGyDVEKNNSRIKLGIKsLVsKG |
| Q02880 | Y1421 | Sugiyama | TOP2B | PItNDGEDEFVPsDGLDKDEytFsPGKSKAtPEKsLHDKKs |
| Q03181 | Y108 | PSP | PPARD NR1C2 PPARB | VHACEGCKGFFRRTIRMKLEyEKCERSCKIQKKNRNKCQYC |
| Q04637 | Y1253 | Sugiyama | EIF4G1 EIF4F EIF4G EIF4GI | LKAALsEEELEKKsKAIIEEyLHLNDMKEAVQCVQELASPS |
| Q04837 | S67 | Sugiyama | SSBP1 SSBP | QVEGKNPVTIFSLATNEMWRsGDsEVyQLGDVsQKTTWHRI |
| Q04837 | Y73 | Sugiyama | SSBP1 SSBP | PVTIFSLATNEMWRsGDsEVyQLGDVsQKTTWHRISVFRPG |
| Q04917 | Y154 | Sugiyama | YWHAH YWHA1 | LAEVASGEKKNsVVEAsEAAyKEAFEISKEQMQPTHPIRLG |
| Q04917 | Y49 | Sugiyama | YWHAH YWHA1 | AVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSIEQK |
| Q05397 | Y194 | SIGNOR|EPSD|PSP | PTK2 FAK FAK1 | LEIRRSYWEMRGNALEKKSNyEVLEKDVGLKRFFPKSLLDS |
| Q05397 | Y5 | SIGNOR|EPSD|PSP | PTK2 FAK FAK1 | ________________MAAAyLDPNLNHtPNsStKTHLGtG |
| Q05639 | Y29 | Sugiyama | EEF1A2 EEF1AL STN | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| Q05682 | Y160 | Sugiyama | CALD1 CAD CDM | DTAENETTEKEEKsESRQERyEIEETEtVtKSYQKNDWRDA |
| Q06830 | Y116 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | GLGPMNIPLVSDPKRtIAQDyGVLKADEGIsFRGLFIIDDK |
| Q07157 | S1065 | Sugiyama | TJP1 ZO1 | YVEKQAsRDLEQPtyRyEsssytDQFsRNYEHRLRYEDRVP |
| Q07157 | Y1066 | Sugiyama | TJP1 ZO1 | VEKQAsRDLEQPtyRyEsssytDQFsRNYEHRLRYEDRVPM |
| Q07157 | Y1191 | Sugiyama | TJP1 ZO1 | LRPEAQPHPsAGPKPAEsKQyFEQysRsyEQVPPQGFTSRA |
| Q07157 | Y669 | Sugiyama | TJP1 ZO1 | IFGPIADVAREKLAREEPDIyQIAKSEPRDAGTDQRSsGII |
| Q07666 | Y145 | Sugiyama | KHDRBS1 SAM68 | LtAEIEKIQKGDSKKDDEENyLDLFsHKNMKLKERVLIPVK |
| Q08043 | Y229 | Sugiyama | ACTN3 | KLRKDDPIGNLNTAFEVAEKyLDIPKMLDAEDIVNtPKPDE |
| Q09472 | S1834 | GPS6 | EP300 P300 | RQQQLQHRLQQAQMLRRRMAsMQRTGVVGQQQGLPSPTPAT |
| Q12809 | Y611 | GPS6 | KCNH2 ERG ERG1 HERG | DQIGKPYNSSGLGGPSIKDKyVTALYFTFSSLTSVGFGNVS |
| Q13017 | Y1109 | Sugiyama | ARHGAP5 RHOGAP5 | DNyAEPIDTIFKQKGYsDEIyVVPDDsQNRIKIRNsFVNNt |
| Q13069 | Y10 | Sugiyama | GAGE5 | ___________MSWRGRsTyyWPRPRRYVQPPEVIGPMRPE |
| Q13069 | Y9 | Sugiyama | GAGE5 | ____________MSWRGRsTyyWPRPRRYVQPPEVIGPMRP |
| Q13070 | Y10 | Sugiyama | GAGE6 | ___________MSWRGRsTyyWPRPRRYVQPPEVIGPMRPE |
| Q13070 | Y9 | Sugiyama | GAGE6 | ____________MSWRGRsTyyWPRPRRYVQPPEVIGPMRP |
| Q13098 | Y172 | Sugiyama | GPS1 COPS1 CSN1 | YKGNSIKESIRRGHDDLGDHyLDCGDLSNALKCYSRARDYC |
| Q13242 | Y17 | Sugiyama | SRSF9 SFRS9 SRP30C | ____MsGWADERGGEGDGRIyVGNLPTDVREKDLEDLFyKY |
| Q13263 | Y133 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | TVVDCPVCKQQCFSKDIVENyFMRDsGsKAATDAQDANQCC |
| Q13263 | Y242 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | ESCDTLTCRDCQLNAHKDHQyQFLEDAVRNQRKLLAsLVKR |
| Q13263 | Y517 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | LtADsQPPVFKVFPGsttEDyNLIVIERGAAAAATGQPGtA |
| Q13310 | Y194 | Sugiyama | PABPC4 APP1 PABP4 | KSRKEREAELGAKAKEFtNVyIKNFGEEVDDEsLKELFsQF |
| Q13315 | Y370 | SIGNOR|EPSD|PSP | ATM | ADICHQVFNEDTRSLEIsQSyTttQRESSDYSVPCKRKKIE |
| Q13371 | Y15 | Sugiyama | PDCL PHLOP1 PhLP1 | ______MTTLDDKLLGEKLQyyysssEDEDsDHEDKDRGRC |
| Q13405 | Y45 | Sugiyama | MRPL49 C11orf4 NOF1 OK/SW-cl.67 | LLSQTQGPPDYPRFVEsVDEyQFVERLLPATRIPDPPKHEH |
| Q13435 | Y591 | Sugiyama | SF3B2 SAP145 | LHDAFFKWQTKPKLTIHGDLyyEGKEFETRLKEKKPGDLSD |
| Q13435 | Y592 | Sugiyama | SF3B2 SAP145 | HDAFFKWQTKPKLTIHGDLyyEGKEFETRLKEKKPGDLSDE |
| Q13442 | T18 | Sugiyama | PDAP1 HASPP28 | ___MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREEE |
| Q13442 | Y17 | Sugiyama | PDAP1 HASPP28 | ____MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREE |
| Q13442 | Y70 | Sugiyama | PDAP1 HASPP28 | DPKKEKKsLDsDEsEDEEDDyQQKRKGVEGLIDIENPNRVA |
| Q13480 | Y285 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | GAB1 | ysHDVLPKVsPsstEADGELyVFNTPSGTSSVETQMRHVsI |
| Q13480 | Y307 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | GAB1 | FNTPSGTSSVETQMRHVsIsyDIPPtPGNtyQIPRTFPEGT |
| Q13480 | Y373 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | GAB1 | DRsPVETCSIPRTAsDTDssyCIPtAGMsPSRSNtIstVDL |
| Q13480 | Y406 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | GAB1 | NtIstVDLNKLRKDAssQDCyDIPRAFPSDRsssLEGFHNH |
| Q13480 | Y447 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | GAB1 | FKVKNVLTVGSVssEELDENyVPMNPNsPPRQHSSSFTEPI |
| Q13480 | Y472 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | GAB1 | PNsPPRQHSSSFTEPIQEANyVPMtPGTFDFSSFGMQVPPP |
| Q13480 | Y589 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | GAB1 | RPDSVHSTTSSSDsHDSEENyVPMNPNLsSEDPNLFGSNSL |
| Q13480 | Y627 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP|Sugiyama | GAB1 | NSLDGGSSPMIKPKGDKQVEyLDLDLDsGKstPPRKQKssG |
| Q13480 | Y659 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | GAB1 | PPRKQKssGsGssVADERVDyVVVDQQKTLALKSTREAWTD |
| Q13501 | Y433 | SIGNOR|PSP | SQSTM1 ORCA OSIL | LTRLLQTKNyDIGAALDTIQySKHPPPL_____________ |
| Q13509 | Y106 | Sugiyama | TUBB3 TUBB4 | RPDNFIFGQSGAGNNWAKGHytEGAELVDsVLDVVRKECEN |
| Q13546 | Y384 | Sugiyama | RIPK1 RIP RIP1 | EHPQEENEPSLQSKLQDEANyHLyGsRMDRQTKQQPRQNVA |
| Q13547 | Y72 | PSP | HDAC1 RPD3L1 | EIYRPHKANAEEMTKYHSDDyIKFLRSIRPDNMsEysKQMQ |
| Q13561 | Y6 | Sugiyama | DCTN2 DCTN50 | _______________MADPKyADLPGIARNEPDVYETSDLP |
| Q13561 | Y86 | Sugiyama | DCTN2 DCTN50 | GLDFsDRIGKTKRtGyEsGEyEMLGEGLGVKETPQQKYQRL |
| Q13573 | Y292 | Sugiyama | SNW1 SKIIP SKIP | GRGLQTVHINENFAKLAEALyIADRKAREAVEMRAQVERKM |
| Q13573 | Y430 | Sugiyama | SNW1 SKIIP SKIP | RLFNQSKGMDSGFAGGEDEIyNVyDQAWRGGKDMAQsIyRP |
| Q13573 | Y459 | Sugiyama | SNW1 SKIIP SKIP | GGKDMAQsIyRPSKNLDKDMyGDDLEARIKTNRFVPDKEFS |
| Q13601 | Y287 | Sugiyama | KRR1 HRB2 | tPFPPPQPESQIDKELAsGEyFLKANQKKRQKMEAIKAKQA |
| Q13642 | Y149 | Sugiyama | FHL1 SLIM1 | CSNCKQVIGtGSFFPKGEDFyCVtCHETKFAKHCVKCNKAI |
| Q13765 | S117 | Sugiyama | NACA HSD48 | RKSKNILFVITKPDVYKSPAsDtyIVFGEAKIEDLsQQAQL |
| Q13765 | Y120 | Sugiyama | NACA HSD48 | KNILFVITKPDVYKSPAsDtyIVFGEAKIEDLsQQAQLAAA |
| Q13885 | Y106 | Sugiyama | TUBB2A TUBB2 | RPDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESES |
| Q14152 | Y697 | Sugiyama | EIF3A EIF3S10 KIAA0139 | LEKEKKELQERLKNQEKKIDyFERAKRLEEIPLIKSAYEEQ |
| Q14157 | S859 | Sugiyama | UBAP2L KIAA0144 NICE4 | FPtPttPLtGRDGsLAsNPysGDLtKFGRGDASSPAPATTL |
| Q14157 | Y858 | Sugiyama | UBAP2L KIAA0144 NICE4 | PFPtPttPLtGRDGsLAsNPysGDLtKFGRGDASSPAPATT |
| Q14160 | Y1360 | Sugiyama | SCRIB CRIB1 KIAA0147 LAP4 SCRB1 VARTUL | PPtPGPAAsPEQLsFRERQKyFELEVRVPQAEGPPKRVsLV |
| Q14164 | Y153 | SIGNOR|EPSD|PSP | IKBKE IKKE IKKI KIAA0151 | HRDIKPGNIMRLVGEEGQsIyKLtDFGAARELDDDEKFVsV |
| Q14164 | Y179 | SIGNOR|EPSD|PSP | IKBKE IKKE IKKI KIAA0151 | GAARELDDDEKFVsVyGtEEyLHPDMYERAVLRKPQQKAFG |
| Q14240 | Y71 | Sugiyama | EIF4A2 DDX2B EIF4F | yGFEKPsAIQQRAIIPCIKGyDVIAQAQsGtGKTATFAISI |
| Q14244 | Y190 | Sugiyama | MAP7 | PSIHSADPDRRsVstMNLsKyVDPVISKRLssssAtLLNsP |
| Q14247 | S418 | Sugiyama | CTTN EMS1 | KtQtPPVsPAPQPtEERLPssPVyEDAAsFKAELsyRGPVs |
| Q14247 | Y141 | Sugiyama | CTTN EMS1 | FGGKFGVQMDRVDQsAVGFEyQGKtEKHAsQKDyssGFGGK |
| Q14247 | Y215 | Sugiyama | CTTN EMS1 | FGGKyGIDKDKVDKsAVGFEyQGKtEKHESQKDyVKGFGGK |
| Q14247 | Y289 | Sugiyama | CTTN EMS1 | FGGKFGVQsERQDsAAVGFDyKEKLAKHEsQQDySKGFGGK |
| Q14247 | Y334 | Sugiyama | CTTN EMS1 | KDRMDKNAstFEDVtQVssAyQKTVPVEAVtsKtsNIRANF |
| Q14247 | Y421 | Sugiyama | CTTN EMS1 | tPPVsPAPQPtEERLPssPVyEDAAsFKAELsyRGPVsGtE |
| Q14247 | Y446 | Sugiyama | CTTN EMS1 | sFKAELsyRGPVsGtEPEPVysMEAADyREASSQQGLAYAT |
| Q14247 | Y545 | Sugiyama | CTTN EMS1 | IDDGWWRGVCKGRyGLFPANyVELRQ_______________ |
| Q14257 | Y311 | Sugiyama | RCN2 ERC55 | NPDLFLtsEAtDyGRQLHDDyFyHDEL______________ |
| Q14257 | Y313 | Sugiyama | RCN2 ERC55 | DLFLtsEAtDyGRQLHDDyFyHDEL________________ |
| Q14257 | Y54 | Sugiyama | RCN2 ERC55 | ERRsDyDREALLGVQEDVDEyVKLGHEEQQKRLQAIIKKID |
| Q14258 | Y245 | Sugiyama | TRIM25 EFP RNF147 ZNF147 | NRQQDVRMTANRKVEQLQQEytEMKALLDASETTSTRKIKE |
| Q14444 | Y99 | Sugiyama | CAPRIN1 GPIAP1 GPIP137 M11S1 RNG105 | QERMNKGERLNQDQLDAVsKyQEVtNNLEFAKELQRsFMAL |
| Q14457 | Y229 | EPSD|PSP | BECN1 GT197 | AENLEKVQAEAERLDQEEAQyQREysEFKRQQLELDDELKS |
| Q14457 | Y233 | EPSD|PSP | BECN1 GT197 | EKVQAEAERLDQEEAQyQREysEFKRQQLELDDELKSVENQ |
| Q14457 | Y352 | EPSD|PSP | BECN1 GT197 | PyGNHsYLESLTDKSKELPLyCSGGLRFFWDNKFDHAMVAF |
| Q14568 | Y160 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | SAYLVAEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGERM |
| Q14568 | Y283 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | sDEEEEKKDGDKKKKKTKEKyIDQEELNKTKPIWTRNPDDI |
| Q14651 | Y463 | Sugiyama | PLS1 | VNKPPYPALGGNMKKIENCNyAVELGKNKAKFSLVGIAGQD |
| Q14671 | Y83 | Sugiyama | PUM1 KIAA0099 PUMH1 | SPVPGSIGVAGRsQDDAMVDyFFQRQHGEQLGGGGsGGGGy |
| Q14692 | Y780 | Sugiyama | BMS1 BMS1L KIAA0187 | TGKWEDDKDAAKVLAEDEELyGDFEDLETGDVHKGKSGPNT |
| Q14764 | Y389 | Sugiyama | MVP LRP | AKVEVVEERQAIPLDENEGIyVQDVKTGKVRAVIGSTYMLT |
| Q14974 | Y529 | Sugiyama | KPNB1 NTF97 | KLLETTDRPDGHQNNLRSSAyEsLMEIVKNSAKDCYPAVQK |
| Q15029 | Y167 | Sugiyama | EFTUD2 KIAA0031 SNRP116 | DCLIEQTHPEIRKRyDQDLCyTDILFTEQERGVGIKSTPVT |
| Q15056 | Y101 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | FKGFCyVEFDEVDsLKEALtyDGALLGDRsLRVDIAEGRKQ |
| Q15056 | Y86 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | sIRsVRLVRDKDTDKFKGFCyVEFDEVDsLKEALtyDGALL |
| Q15181 | Y169 | Sugiyama | PPA1 IOPPP PP | EGETDWKVIAINVDDPDAANyNDINDVKRLKPGYLEATVDW |
| Q15293 | Y140 | Sugiyama | RCN1 RCN | VAKVWKDYDRDKDDKISWEEyKQAtyGyyLGNPAEFHDssD |
| Q15293 | Y147 | Sugiyama | RCN1 RCN | YDRDKDDKISWEEyKQAtyGyyLGNPAEFHDssDHHtFKKM |
| Q15293 | Y148 | Sugiyama | RCN1 RCN | DRDKDDKISWEEyKQAtyGyyLGNPAEFHDssDHHtFKKML |
| Q15293 | Y278 | Sugiyama | RCN1 RCN | LNKDGKLDKDEIRHWILPQDyDHAQAEARHLVyESDKNKDE |
| Q15293 | Y320 | Sugiyama | RCN1 RCN | LTKEEILENWNMFVGsQAtNyGEDLtKNHDEL_________ |
| Q15369 | Y18 | Sugiyama | ELOC TCEB1 | ___MDGEEKtyGGCEGPDAMyVKLISSDGHEFIVKREHALt |
| Q15424 | Y723 | Sugiyama | SAFB HAP HET SAFB1 | EQERRPAVRRPYDLDRRDDAyWPEAKRAALDERYHSDFNRQ |
| Q15427 | Y16 | Sugiyama | SF3B4 SAP49 | _____MAAGPISERNQDAtVyVGGLDEKVSEPLLWELFLQA |
| Q15459 | Y456 | Sugiyama | SF3A1 SAP114 | PRWLEQRDRSIREKQsDDEVyAPGLDIESsLKQLAERRtDI |
| Q15527 | Y123 | Sugiyama | SURF2 | GRRYQRALCKYEECQKQGVEyVPACLVHRRRRREDQMDGDG |
| Q15637 | Y87 | Sugiyama | SF1 ZFM1 ZNF162 | tGDLGIPPNPEDRsPsPEPIyNsEGKRLNTREFRTRKKLEE |
| Q15645 | Y206 | PSP | TRIP13 PCH2 | TSLCKALAQKLTIRLSSRYRyGQLIEINSHSLFSKWFSESG |
| Q15645 | Y56 | SIGNOR|PSP | TRIP13 PCH2 | EDINLsVRKLLNRHNIVFGDyTWTEFDEPFLTRNVQSVSII |
| Q15648 | Y1476 | Sugiyama | MED1 ARC205 CRSP1 CRSP200 DRIP205 DRIP230 PBP PPARBP PPARGBP RB18A TRAP220 TRIP2 | ytPQNLDsEsEsGSSIAEKsyQNsPssDDGIRPLPEYstEK |
| Q15650 | Y289 | Sugiyama | TRIP4 RQT4 | LLEFDRtsIRRtQVIDDESDyFASDSNQWLSKLERETLQKR |
| Q15650 | Y345 | Sugiyama | TRIP4 RQT4 | KVTIDFAGRKILEEENsLAEyHSRLDETIQAIANGTLNQPL |
| Q16143 | Y39 | Sugiyama | SNCB | AEKTKQGVTEAAEKTKEGVLyVGsKTREGVVQGVASVAEKT |
| Q16595 | Y95 | Sugiyama | FXN FRDA X25 | LMNLRKsGtLGHPGsLDEttyERLAEETLDSLAEFFEDLAD |
| Q32MZ4 | Y597 | Sugiyama | LRRFIP1 GCF2 TRIP | KKKKsPVPVETLKDVKKELtyQNTDLsEIKEEEQVKstDRK |
| Q38SD2 | Y971 | SIGNOR|EPSD|PSP | LRRK1 KIAA1790 | AEDLRMLLVGTGFTQQTEEQyFQFLAKFEIALPVANDSYLL |
| Q3V6T2 | Y1765 | PSP | CCDC88A APE GRDN KIAA1212 | DRRTTKPEFLRPGPRKTEDtyFISSAGKPTPGTQGKIKLVK |
| Q3V6T2 | Y1799 | PSP | CCDC88A APE GRDN KIAA1212 | GKIKLVKEssLSRQSKDSNPyAtLPRASSVISTAEGttRRt |
| Q4LE39 | Y795 | Sugiyama | ARID4B BRCAA1 RBBP1L1 RBP1L1 SAP180 | VsKsPERLRKDIEVLsEDtDyEEDEVTKKRKDVKKDTTDKS |
| Q53H82 | Y121 | Sugiyama | LACTB2 CGI-83 | IKKLPRNPQREEIIGNGEQQyVyLKDGDVIKTEGATLRVLY |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q56P03 | Y106 | Sugiyama | EAPP C14orf11 BM-036 | GsssGNGKVATAPTRyYDDIyFDsDsEDEDRAVQVtKKKKK |
| Q58FF3 | Y58 | Sugiyama | HSP90B2P GRP94B GRP94P1 TRAP1 | VTFKSILFVPTFVPRGLFDEyGsKKSDYIKLYVRCVFITDD |
| Q58FF6 | Y167 | Sugiyama | HSP90AB4P | GEPIDRDTKVILHLKEDQtEyLEERWVKEVVKKHPQFIGCL |
| Q58FF7 | Y171 | Sugiyama | HSP90AB3P HSP90BC | GEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIGyP |
| Q58FF8 | Y198 | Sugiyama | HSP90AB2P HSP90BB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKTKPIWTRNTEDI |
| Q58FF8 | Y260 | Sugiyama | HSP90AB2P HSP90BB | VRYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVW |
| Q58FF8 | Y261 | Sugiyama | HSP90AB2P HSP90BB | RYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVWK |
| Q58FG0 | Y177 | Sugiyama | HSP90AA5P HSP90AE | GQLEELKDSRRVMKANQKHIyyItGETKDQVANSAFVECLQ |
| Q58FG0 | Y178 | Sugiyama | HSP90AA5P HSP90AE | QLEELKDSRRVMKANQKHIyyItGETKDQVANSAFVECLQK |
| Q5JTH9 | Y1251 | Sugiyama | RRP12 KIAA0690 | AEYKAKKAKGDVKKKGRPDPyAyIPLNRSKLNRRKKMKLQG |
| Q5T035 | Y67 | Sugiyama | FAM120A2P C9orf129 | SEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyERSLPIN |
| Q5VTE0 | Y29 | Sugiyama | EEF1A1P5 EEF1AL3 | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| Q5VV41 | Y216 | Sugiyama | ARHGEF16 EPHEXIN4 NBR | KKTLGRKRGHKGsFKDDPQLyQEIQERGLNtsQEsDDDILD |
| Q6PKG0 | Y633 | Sugiyama | LARP1 KIAA0731 LARP | MEQMDGRKNtFtAWsDEEsDyEIDDRDVNKILIVtQtPHyM |
| Q6PKG0 | Y699 | Sugiyama | LARP1 KIAA0731 LARP | INDGLFyyEQDLWAEKFEPEysQIKQEVENFKKVNMISREQ |
| Q6S8J3 | Y1062 | Sugiyama | POTEE A26C1A POTE2 | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q6WKZ4 | Y1254 | Sugiyama | RAB11FIP1 RCP | VLKQKETISKKEFQVRELEDyIDNLLVRVMEETPNILRIPT |
| Q6ZSR9 | Y28 | Sugiyama | None | LYPDPSRVPGTKTQNNLESDyLARDGPSSNSSFHSSEEEGT |
| Q71U36 | S439 | Sugiyama | TUBA1A TUBA3 | SEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy________ |
| Q71U36 | Y432 | Sugiyama | TUBA1A TUBA3 | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q7KZF4 | Y476 | Sugiyama | SND1 TDRD11 | SKGLATVIRYRQDDDQRssHyDELLAAEARAIKNGKGLHSK |
| Q7L804 | Y480 | Sugiyama | RAB11FIP2 KIAA0941 | LVKHKELLRRKDTHIRELEDyIDNLLVRVMEETPSILRVPY |
| Q7Z3K3 | S35 | Sugiyama | POGZ KIAA0461 SUHW5 ZNF280E ZNF635 Nbla00003 | LEPWQKISDVIEDsVVEDyNsVDKTTTVSVSQQPVSAPVPI |
| Q7Z3K3 | Y33 | Sugiyama | POGZ KIAA0461 SUHW5 ZNF280E ZNF635 Nbla00003 | EELEPWQKISDVIEDsVVEDyNsVDKTTTVSVSQQPVSAPV |
| Q7Z417 | Y265 | Sugiyama | NUFIP2 KIAA1321 PIG1 | MQQETsVPTLKQGLEtFKPDysEQKGNRVDGSKPIWKYETG |
| Q7Z699 | S105 | SIGNOR|PSP | SPRED1 | VTPTFHHWKIDDKKFGLTFQsPADARAFDRGIRRAIEDISQ |
| Q86SX6 | Y88 | Sugiyama | GLRX5 C14orf87 | GFSNAVVQILRLHGVRDyAAyNVLDDPELRQGIKDYSNWPT |
| Q86UK7 | Y306 | Sugiyama | ZNF598 | QFSYAPRHSRRNEGVVGGEDyEEVDRysRQGRVARAGTRGA |
| Q86V81 | Y250 | Sugiyama | ALYREF ALY BEF THOC4 | AGRNSKQQLsAEELDAQLDAyNARMDts_____________ |
| Q86VS8 | Y171 | Sugiyama | HOOK3 | MTAIQELMSKEsPVSAGNDAyVDLDRQLKKTTEELNEALSA |
| Q86W56 | Y832 | Sugiyama | PARG | DDWQRRCTEIVAIDALHFRRyLDQFVPEKMRRELNKAYCGF |
| Q86WV6 | Y245 | PSP | STING1 ERIS MITA STING TMEM173 | LPQQtGDHAGIKDRVysNsIyELLENGQRAGTCVLEYATPL |
| Q8IVM0 | Y217 | SIGNOR|EPSD|PSP | CCDC50 C3orf6 | AQVAQDEEIARLLMAEEKKAyKKAKEREKSSLDKRKQDPEW |
| Q8IVM0 | Y279 | SIGNOR|EPSD|PSP | CCDC50 C3orf6 | KNERPARPPPPIMtDGEDADytHFTNQQssTRHFSKSESSH |
| Q8IVM0 | Y304 | SIGNOR|EPSD|PSP | CCDC50 C3orf6 | NQQssTRHFSKSESSHKGFHyKH__________________ |
| Q8IZ21 | Y647 | Sugiyama | PHACTR4 PRO2963 | LsQRPtVAELLARKILRFNEyVEVTDAQDYDRRADKPWTKL |
| Q8N0Y7 | S134 | Sugiyama | PGAM4 PGAM3 | IWRRsyDVPPPPMEPDHPFysNIsKDRRYADLTEDQLPSYE |
| Q8N3D4 | T1359 | Sugiyama | EHBP1L1 | PSEEPPPSPGEEAGLQRFQDtsQyVCAELQALEQEQRQIDG |
| Q8N6H7 | Y278 | Sugiyama | ARFGAP2 ZNF289 Nbla10535 | QAADAKKQAEESMVASMRLAyQELQIDRKKEEKKLQNLEGK |
| Q8N6T3 | Y175 | Sugiyama | ARFGAP1 ARF1GAP | sVtAssDKAFEDWLNDDLGsyQGAQGNRyVGFGNtPPPQKK |
| Q8N7H5 | Y169 | Sugiyama | PAF1 PD2 | EKPEVKIGVSVKQQFTEEEIyKDRDSQITAIEKTFEDAQKS |
| Q8N7H5 | Y322 | Sugiyama | PAF1 PD2 | KASKGyEENyFFIFREGDGVyyNELETRVRLSKRRAKAGVQ |
| Q8NBS9 | Y251 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | ALGLEHSETVKIGKVDCtQHyELCsGNQVRGyPtLLWFRDG |
| Q8NBS9 | Y289 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | RDGKKVDQYKGKRDLEsLREyVEsQLQRTETGATETVTPSE |
| Q8ND56 | Y455 | Sugiyama | LSM14A C19orf13 FAM61A RAP55 RAP55A | RGFRGGFRGGRGGREFADFEyRKTTAFGP____________ |
| Q8NFJ5 | Y317 | EPSD|PSP | GPRC5A GPCR5A RAI3 RAIG1 | NRAysQEEItQGFEEtGDtLyAPystHFQLQNQPPQKEFsI |
| Q8NFJ5 | Y320 | EPSD|PSP | GPRC5A GPCR5A RAI3 RAIG1 | ysQEEItQGFEEtGDtLyAPystHFQLQNQPPQKEFsIPRA |
| Q8NFJ5 | Y347 | EPSD|PSP | GPRC5A GPCR5A RAI3 RAIG1 | QNQPPQKEFsIPRAHAWPsPyKDyEVKKEGS__________ |
| Q8NFJ5 | Y350 | EPSD|PSP | GPRC5A GPCR5A RAI3 RAIG1 | PPQKEFsIPRAHAWPsPyKDyEVKKEGS_____________ |
| Q8NI22 | Y135 | Sugiyama | MCFD2 SDNSF | DELINIIDGVLRDDDKNNDGyIDyAEFAKSLQ_________ |
| Q8NI22 | Y138 | Sugiyama | MCFD2 SDNSF | INIIDGVLRDDDKNNDGyIDyAEFAKSLQ____________ |
| Q8TDD1 | Y681 | Sugiyama | DDX54 | GPNRGAKRRREEARQRDQEFyIPyRPKDFDSERGLsIsGEG |
| Q8TDY4 | Y34 | SIGNOR|EPSD|PSP | ASAP3 DDEFL1 UPLC1 | TAEDLSSPAGAAAFAAKMPRyRGAALAREEILEGDQAILQR |
| Q8TEW0 | Y1080 | Sugiyama | PARD3 PAR3 PAR3A | QERIQAKTREFRERQARERDyAEIQDFHRTFGCDDELMYGG |
| Q8TEW0 | Y388 | Sugiyama | PARD3 PAR3 PAR3A | QLSQSEKNNyyssRFsPDsQyIDNRSVNSAGLHTVQRAPRL |
| Q8WUA2 | Y401 | Sugiyama | PPIL4 | TSKKHKKKTHHCsEEKEDEDyMPIKNTNQDIYREMGFGHYE |
| Q8WWF6 | Y53 | Sugiyama | DNAJB3 HCG3 | DKNPENKEEAERRFKQVAEAyEVLSDAKKRDIYDRYGEAGA |
| Q8WYP5 | Y1790 | Sugiyama | AHCTF1 ELYS TMBS62 MSTP108 | QSVRKKTRKAKEISEASENIySDVRGLsQNQQIPQNsVtPR |
| Q92785 | Y172 | Sugiyama | DPF2 BAF45D REQ UBID4 | RARKRILEPDDFLDDLDDEDyEEDtPKRRGKGKSKGKGVGS |
| Q92796 | Y673 | Sugiyama | DLG3 KIAA1232 | GSCVPHTTRPRRDNEVDGQDyHFVVsREQMEKDIQDNKFIE |
| Q92882 | Y207 | Sugiyama | OSTF1 | sLLKKKQGTDAVRtLsNAEDyLDDEDsD_____________ |
| Q92905 | Y203 | Sugiyama | COPS5 CSN5 JAB1 | LGAFRTYPKGYKPPDEGPsEyQtIPLNKIEDFGVHCKQYYA |
| Q92952 | Y109 | SIGNOR|EPSD|PSP | KCNN1 SK | VGHRLGHRRALFEKRKRLSDyALIFGMFGIVVMVTETELSW |
| Q969T4 | Y91 | Sugiyama | UBE2E3 UBCE4 UBCH9 | AEITLDPPPNCSAGPKGDNIyEWRSTILGPPGSVYEGGVFF |
| Q96A49 | Y327 | Sugiyama | SYAP1 PRO3113 | AVLEEDsADWEKELQQELQEyEVVtESEKRDENWDKEIEKM |
| Q96AE4 | Y58 | Sugiyama | FUBP1 | ARQIAAKIGGDAGtsLNsNDyGyGGQKRPLEDGDQPDAKKV |
| Q96AE4 | Y60 | Sugiyama | FUBP1 | QIAAKIGGDAGtsLNsNDyGyGGQKRPLEDGDQPDAKKVAP |
| Q96AE4 | Y626 | Sugiyama | FUBP1 | GGQPDYSAAWAEYYRQQAAyyAQtsPQGMPQHPPAPQGQ__ |
| Q96C90 | Y29 | Sugiyama | PPP1R14B PLCB3N PNG | GAALAAPAPGPGsGGPGPRVyFQsPPGAAGEGPGGADDEGP |
| Q96CT7 | Y38 | Sugiyama | CCDC124 | RRAEAKAAADAKKQKELEDAyWKDDDKHVMRKEQRKEEKEK |
| Q96D15 | Y125 | Sugiyama | RCN3 UNQ239/PRO272 | WIAHTQQRHIRDsVsAAWDtyDtDRDGRVGWEELRNATYGH |
| Q96EU6 | Y138 | Sugiyama | RRP36 C6orf153 HSPC253 | RDPRFDDLSGEYNPEVFDKtyQFLNDIRAKEKELVKKQLKK |
| Q96FA3 | T264 | SIGNOR | PELI1 PRISM | IDLCGATLLWRTAEGLSHTPtVKHLEALRQEINAARPQCPV |
| Q96FA3 | Y154 | SIGNOR | PELI1 PRISM | ISRFACRIICERNPPFTARIyAAGFDSSKNIFLGEKAAKWK |
| Q96GX9 | Y57 | Sugiyama | APIP CGI-29 | HLGWVTGTGGGISLKHGDEIyIAPsGVQKERIQPEDMFVCD |
| Q96HC4 | Y251 | Sugiyama | PDLIM5 ENH L9 | DSKQQNGPPRKHIVERytEFyHVPtHsDAsKKRLIEDTEDW |
| Q96I25 | Y194 | Sugiyama | RBM17 SPF45 | AIAPPTSLVEKDKELPRDFPyEEDSRPRsQsSKAAIPPPVy |
| Q96I25 | Y214 | Sugiyama | RBM17 SPF45 | yEEDSRPRsQsSKAAIPPPVyEEQDRPRsPtGPsNsFLANM |
| Q96LR5 | Y85 | Sugiyama | UBE2E2 UBCH8 | AEITLDPPPNCSAGPKGDNIyEWRSTILGPPGSVYEGGVFF |
| Q96P70 | Y889 | Sugiyama | IPO9 IMP9 KIAA1192 RANBP9 HSPC273 | HGINADDKRLQDIRVKGEEIysMDEGIRTRSKSAKNPERWT |
| Q96QK1 | Y507 | Sugiyama | VPS35 MEM3 TCCCTA00141 | EQSLVGRFIHLLRsEDPDQQyLILNTARKHFGAGGNQRIRF |
| Q96TA1 | Y593 | SIGNOR|EPSD|PSP | NIBAN2 C9orf88 FAM129B | NsDPNLHLLAEGAPIDWGEEySNSGGGGSPSPSTPESATLS |
| Q99459 | Y511 | Sugiyama | CDC5L KIAA0432 PCDC5RP | EIVLPENAEKELEEREIDDtyIEDAADVDARKQAIRDAERV |
| Q99459 | Y788 | Sugiyama | CDC5L KIAA0432 PCDC5RP | ECLKEDVQRQQEREKELQHRyADLLLEKETLKSKF______ |
| Q99614 | S90 | Sugiyama | TTC1 TPR1 | FEEEPGADKVENKsNEDVNssELDEEyLIELEKNMSDEEKQ |
| Q99614 | Y132 | Sugiyama | TTC1 TPR1 | RREESTRLKEEGNEQFKKGDyIEAESSYSRALEMCPSCFQK |
| Q99614 | Y212 | Sugiyama | TTC1 TPR1 | ILRRAELYEKTDKLDEALEDyKSILEKDPSIHQAREACMRL |
| Q99614 | Y96 | Sugiyama | TTC1 TPR1 | ADKVENKsNEDVNssELDEEyLIELEKNMSDEEKQKRREES |
| Q99848 | Y265 | Sugiyama | EBNA1BP2 EBP2 | NQKFGFGGKKKGSKWNtREsyDDVssFRAKTAHGRGLKRPG |
| Q99961 | Y57 | Sugiyama | SH3GL1 CNSA1 SH3D2B | EKKVDVTSKAVTEVLARTIEyLQPNPAsRAKLTMLNTVSKI |
| Q99962 | Y57 | Sugiyama | SH3GL2 CNSA2 SH3D2A | ERKVDVTSRAVMEIMTKTIEyLQPNPAsRAKLSMINTMsKI |
| Q9BQE3 | Y432 | Sugiyama | TUBA1C TUBA6 | GMEEGEFSEAREDMAALEKDyEEVGADsADGEDEGEEy___ |
| Q9BQE3 | Y449 | Sugiyama | TUBA1C TUBA6 | EKDyEEVGADsADGEDEGEEy____________________ |
| Q9BRK5 | Y342 | Sugiyama | SDF4 CAB45 PSEC0034 | MIAVADENQNHHLEPEEVLKysEFFTGSKLVDYARsVHEEF |
| Q9BS26 | T398 | Sugiyama | ERP44 KIAA0573 TXNDC4 UNQ532/PRO1075 | VASSPPESSFQKLAPsEyRytLLRDRDEL____________ |
| Q9BS26 | Y395 | Sugiyama | ERP44 KIAA0573 TXNDC4 UNQ532/PRO1075 | AQDVASSPPESSFQKLAPsEyRytLLRDRDEL_________ |
| Q9BVA1 | Y106 | Sugiyama | TUBB2B | RPDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESES |
| Q9BXS6 | Y370 | Sugiyama | NUSAP1 ANKT BM-037 PRO0310 | PVsNKKPVFDLKAsLsRPLNyEPHKGKLKPWGQSKENNyLN |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9BYX7 | Y362 | Sugiyama | POTEKP ACTBL3 FKSG30 | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| Q9BZI7 | Y167 | Sugiyama | UPF3B RENT3B UPF3X | RDTKVGtIDDDPEyRKFLEsyAtDNEKMTstPEtLLEEIEA |
| Q9C0C2 | Y1122 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | FsPGQQDWsRDFCIEASERsyQFGIIGNDRVsGAGFsPssK |
| Q9C0C2 | Y897 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | ssRDVsLGDWEFGKRDsLGAyAsQDANEQGQDLGKRDHHGR |
| Q9C0C2 | Y961 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | GSRAAEPQEQEFGKSAWIRDyssGGsSRtLDAQDRsFGtRP |
| Q9GZY8 | Y35 | Sugiyama | MFF C2orf33 AD030 AD033 GL004 | SRAAFPsPTAAEMAEISRIQyEMEyTEGISQRMRVPEKLKV |
| Q9GZY8 | Y39 | Sugiyama | MFF C2orf33 AD030 AD033 GL004 | FPsPTAAEMAEISRIQyEMEyTEGISQRMRVPEKLKVAPPN |
| Q9H1E3 | S149 | Sugiyama | NUCKS1 NUCKS JC7 | DsGsDEDFLMEDDDDsDyGSsKKKNKKMVKKSKPERKEKKM |
| Q9H1E3 | Y146 | Sugiyama | NUCKS1 NUCKS JC7 | QEKDsGsDEDFLMEDDDDsDyGSsKKKNKKMVKKSKPERKE |
| Q9H1E3 | Y26 | Sugiyama | NUCKS1 NUCKS JC7 | RNRKVVDysQFQEsDDADEDyGRDsGPPtKKIRSsPREAKN |
| Q9H4F8 | Y407 | Sugiyama | SMOC1 | FKRYVKKKAKPKKCARRFtDyCDLNKDKVISLPELKGCLGV |
| Q9H4L7 | Y217 | Sugiyama | SMARCAD1 KIAA1122 | MFGDAGGGPRKRKLssssEPyEEDEFNDDQSIKKtRLDHGE |
| Q9H6F5 | S110 | Sugiyama | CCDC86 CYCLON | AsPQRQQDLHLEsPQRQPEysPEsPRCQPKPSEEAPKCsQD |
| Q9H6F5 | Y109 | Sugiyama | CCDC86 CYCLON | AAsPQRQQDLHLEsPQRQPEysPEsPRCQPKPSEEAPKCsQ |
| Q9H788 | Y131 | Sugiyama | SH2D4A PPP1R38 SH2A | EEPRKTHsEEFTNsLKTKsQyHDLQAPDNQQtKDIWKKVAE |
| Q9H814 | Y309 | Sugiyama | PHAX RNUXA | FLNLLKNtPsISEEQIKDIFyIENQKEYENKKAARKRRTQV |
| Q9H814 | Y57 | Sugiyama | PHAX RNUXA | GDsAMRAFQNTAtACAPVSHyRAVESVDSSEESFSDSDDDS |
| Q9H9Y2 | Y287 | Sugiyama | RPF1 BXDC5 | FPHNPQFIGRQVATFHNQRDyIFFRFHRYIFRSEKKVGIQE |
| Q9HCN8 | Y81 | Sugiyama | SDF2L1 UNQ1941/PRO4424 | GSGSGQQSVtGVEAsDDANSyWRIRGGSEGGCPRGSPVRCG |
| Q9HDC5 | Y417 | Sugiyama | JPH1 JP1 | AARQECDIARAVARELsPDFyQPGPDyVKQRFQEGVDAKEN |
| Q9HDC5 | Y423 | Sugiyama | JPH1 JP1 | DIARAVARELsPDFyQPGPDyVKQRFQEGVDAKENPEEKVP |
| Q9NP61 | Y408 | Sugiyama | ARFGAP3 ARFGAP1 | ETVLKTTGYSDRPTARRKPDyEPVENTDEAQKKFGNVKAIs |
| Q9NP74 | Y257 | Sugiyama | PALMD C1orf11 PALML | VEVEELLRQASERNsKsPtEyHEPVyANPFyRPttPQREtV |
| Q9NP74 | Y262 | Sugiyama | PALMD C1orf11 PALML | LLRQASERNsKsPtEyHEPVyANPFyRPttPQREtVtPGPN |
| Q9NRX4 | Y113 | Sugiyama | PHPT1 PHP14 CGI-202 HSPC141 | ysMAyGPAQHAISTEKIKAKyPDyEVtWANDGy________ |
| Q9NRX4 | Y52 | Sugiyama | PHPT1 PHP14 CGI-202 HSPC141 | RSGAPAAESKEIVRGYKWAEyHADIyDKVSGDMQKQGCDCE |
| Q9NRX4 | Y57 | Sugiyama | PHPT1 PHP14 CGI-202 HSPC141 | AAESKEIVRGYKWAEyHADIyDKVSGDMQKQGCDCECLGGG |
| Q9NUL3 | Y326 | Sugiyama | STAU2 | MNPISRLAQIQQAKKEKEPDyVLLSERGMPRRREFVMQVKV |
| Q9NVS9 | Y195 | Sugiyama | PNPO | SSVIPDREYLRKKNEELEQLyQDQEVPKPKSWGGYVLYPQV |
| Q9NVS9 | Y256 | Sugiyama | PNPO | LPtGDsPLGPMTHRGEEDWLyERLAP_______________ |
| Q9NVU7 | Y580 | Sugiyama | SDAD1 NUC130 | RMAQMRKELDAAPGKSQKRKyIEIDsDEEPRGELLsLRDIE |
| Q9NW64 | Y116 | Sugiyama | RBM22 ZC3H16 199G4 | VRDAGLSFKDDMPKSDVNKEyyTQNMEREISNsDGTRPVGM |
| Q9NWS0 | Y194 | Sugiyama | PIH1D1 NOP17 | IsQQNIRSEQRPRIQELGDLytPAPGRAESGPEKPHLNLWL |
| Q9NYF8 | Y383 | Sugiyama | BCLAF1 BTF KIAA0164 | EKGSEKGRAEGEWEDQEALDyFsDKEsGKQKFNDsEGDDtE |
| Q9NYF8 | Y408 | Sugiyama | BCLAF1 BTF KIAA0164 | EsGKQKFNDsEGDDtEEtEDyRQFRKsVLADQGKsFATAsH |
| Q9NYU2 | Y449 | Sugiyama | UGGT1 GT UGCGL1 UGGT UGT1 UGTR | IEGLSLHNVLKLNIQPsEADyAVDIRSPAISWVNNLEVDSR |
| Q9NZB2 | Y418 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | SEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyERssPIN |
| Q9P0J1 | Y381 | EPSD|PSP | PDP1 PDP PPM2C | SIDLQKRVIESGPDQLNDNEytKFIPPNYHTPPYLTAEPEV |
| Q9P0P0 | Y152 | Sugiyama | RNF181 HSPC238 | RDKARKQQQQHRLENLHGAMyt___________________ |
| Q9P219 | Y2025 | EPSD|PSP | CCDC88C DAPLE KIAA1509 | SKSSPASPEPGGDPQTVWyEyGCV_________________ |
| Q9UBB9 | Y51 | Sugiyama | TFIP11 STIP HSPC006 | LQNEFNPNRQRHWQTKEEAtyGVWAERDsDDERPSFGGKRA |
| Q9UBN7 | Y570 | SIGNOR|EPSD|PSP | HDAC6 KIAA0901 JM21 | ATEKMKTRELHRESSNFDSIyICPSTFACAQLATGAACRLV |
| Q9UBR2 | Y76 | Sugiyama | CTSZ | YLSPADLPKSWDWRNVDGVNyAsItRNQHIPQYCGSCWAHA |
| Q9UHI6 | Y659 | Sugiyama | DDX20 DP103 GEMIN3 | RVPVLASSsQsGDsEsDSDSySSRTSSQSKGNKsyLEGssD |
| Q9UHR4 | Y380 | Sugiyama | BAIAP2L1 IRTKS | SFAQGDVITLLIPEEKDGWLyGEHDVSKARGWFPssYTKLL |
| Q9UHR5 | Y46 | Sugiyama | SAP30BP HCNGP HTRG HTRP | AGIEAVGSAAEEKGGLVsDAyGEDDFsRLGGDEDGYEEEED |
| Q9UI15 | Y192 | Sugiyama | TAGLN3 NP25 | NVIGLQMGSNKGAsQAGMtGyGMPRQIM_____________ |
| Q9UII2 | Y58 | Sugiyama | ATP5IF1 ATPI ATPIF1 | GsIREAGGAFGKREQAEEERyFRAQsREQLAALKKHHEEEI |
| Q9UIQ6 | Y70 | Sugiyama | LNPEP OTASE | GsRLLVRGLGEHEMEEDEEDyEssAKLLGMsFMNRssGLRN |
| Q9UJM3 | Y394 | SIGNOR | ERRFI1 MIG6 | sKVPCILPIIENGKKVsstHyyLLPERPPYLDKYEKFFREA |
| Q9UK17 | Y136 | SIGNOR|EPSD|PSP | KCND3 | DELAFYGILPEIIGDCCYEEyKDRKRENAERLMDDNDSENN |
| Q9UKV3 | Y1086 | Sugiyama | ACIN1 ACINUS KIAA0670 | RTALHGVKWPQSNPKFLCADyAEQDELDyHRGLLVDRPsEt |
| Q9UKV8 | Y393 | EPSD|PSP | AGO2 EIF2C2 | PDRQEEISKLMRsAsFNTDPyVREFGIMVKDEMTDVTGRVL |
| Q9UKY7 | Y244 | Sugiyama | CDV3 H41 | NRGRDEVSKNQALKLQLDNQyAVLENQKSSHSQYN______ |
| Q9UMX5 | Y65 | Sugiyama | NENF CIR2 SPUF | RLFtEEELARYGGEEEDQPIyLAVKGVVFDVtSGKEFYGRG |
| Q9UNZ2 | Y167 | Sugiyama | NSFL1C UBXN2C | PRPFAGGGYRLGAAPEEEsAyVAGEKRQHssQDVHVVLKLW |
| Q9UPQ0 | Y179 | Sugiyama | LIMCH1 KIAA1102 | QMRKDTDDIEsPKRSIRDsGyIDCWDsERsDsLsPPRHGRD |
| Q9UQ80 | Y98 | Sugiyama | PA2G4 EBP1 | TSISVNNCVCHFsPLKSDQDyILKEGDLVKIDLGVHVDGFI |
| Q9UQB8 | Y164 | Sugiyama | BAIAP2 | LRKKSQGSKNPQKYSDKELQyIDAISNKQGELENyVSDGYK |
| Q9Y237 | S72 | Sugiyama | PIN4 | MEAMEKLKSGMRFNEVAAQysEDKARQGGDLGWMTRGSMVG |
| Q9Y281 | T88 | Sugiyama | CFL2 | YtsFVKLLPLNDCRyALyDAtyEtKESKKEDLVFIFWAPES |
| Q9Y281 | Y82 | Sugiyama | CFL2 | DTVEDPYtsFVKLLPLNDCRyALyDAtyEtKESKKEDLVFI |
| Q9Y281 | Y89 | Sugiyama | CFL2 | tsFVKLLPLNDCRyALyDAtyEtKESKKEDLVFIFWAPESA |
| Q9Y2B0 | Y71 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | IQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEICDRMKE |
| Q9Y2B0 | Y92 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | ARsEAHLtELLEEICDRMKEyGEQIDPstHRKNYVRVVGRN |
| Q9Y2T3 | Y441 | Sugiyama | GDA KIAA1258 | SEAVIQKFLyLGDDRNIEEVyVGGKQVVPFSSsV_______ |
| Q9Y2T7 | Y107 | Sugiyama | YBX2 CSDA3 MSY2 | KPVLAIQVLGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIK |
| Q9Y2W1 | T230 | Sugiyama | THRAP3 BCLAF2 TRAP150 | tsQDTKAsEssKPWPDAtyGtGsAsRAsAVsELsPRERsPA |
| Q9Y2W1 | Y228 | Sugiyama | THRAP3 BCLAF2 TRAP150 | GGtsQDTKAsEssKPWPDAtyGtGsAsRAsAVsELsPRERs |
| Q9Y2W2 | Y124 | Sugiyama | WBP11 NPWBP SIPP1 SNP70 | YKELRKLEVEYEQKRAQLSQyFDAVKNAQHVEVESIPLPDM |
| Q9Y2W2 | Y236 | Sugiyama | WBP11 NPWBP SIPP1 SNP70 | GRKVGFALDLPPRRRDEDMLysPELAQRGHDDDVSSTSEDD |
| Q9Y3C1 | Y118 | Sugiyama | NOP16 CGI-117 HSPC111 | EAEASLPEKKGNTLSRDLIDyVRYMVENHGEDYKAMARDEK |
| Q9Y3F4 | T109 | Sugiyama | STRAP MAWD UNRIP | VSGDELMTLAHKHIVKtVDFtQDSNyLLtGGQDKLLRIYDL |
| Q9Y3S2 | Y315 | Sugiyama | ZNF330 NOA36 | ssDLFTNLNLGRTYAsGYAHyEEQEN_______________ |
| Q9Y3U8 | Y53 | Sugiyama | RPL36 | LTKHTKFVRDMIREVCGFAPyERRAMELLKVSKDKRALKFI |
| Q9Y450 | Y58 | Sugiyama | HBS1L HBS1 KIAA1038 | AQFIYSRRDKPsVEPVEEyDyEDLKEssNsVsNHQLSGFDQ |
| Q9Y4H2 | Y632 | Sugiyama | IRS2 | LCPsCPAssPKVAyHPyPEDyGDIEIGsHRssssNLGADDG |
| Q9Y4H2 | Y919 | Sugiyama | IRS2 | PSLPSMHEYPLPPEPKsPGEyINIDFGEPGARLsPPAPPLL |
| Q9Y4L1 | Y759 | Sugiyama | HYOU1 GRP170 HSPH4 ORP150 | AANsLEAFIFEtQDKLyQPEyQEVsTEEQREEISGKLSAAS |
| Q9Y5Q8 | Y393 | Sugiyama | GTF3C5 CDABP0017 | SGtsGARKPASSKYKLKDSVyIFREGALPPYRQMFYQLCDL |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
| Q9Y5S9 | Y54 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KRKGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWI |
| Q9Y639 | Y216 | Sugiyama | NPTN SDFR1 SDR1 | KNASNMEYRINKPRAEDsGEyHCVyHFVsAPKANATIEVKA |
| Q9Y639 | Y220 | Sugiyama | NPTN SDFR1 SDR1 | NMEYRINKPRAEDsGEyHCVyHFVsAPKANATIEVKAAPDI |
| Q9Y696 | Y244 | Sugiyama | CLIC4 | AysRDEFtNtCPsDKEVEIAysDVAKRLTK___________ |
| Q9Y6N7 | Y1114 | Sugiyama | ROBO1 DUTT1 | sGEKHWKPLGQQKQEVAPVQyNIVEQNKLNKDYRANDTVPP |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.107413e-10 | 9.956 | 1 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.618035e-10 | 9.791 | 1 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 7.661431e-10 | 9.116 | 1 | 1 |
| MAPK family signaling cascades | R-HSA-5683057 | 2.058714e-09 | 8.686 | 1 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 2.883827e-08 | 7.540 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 7.554573e-08 | 7.122 | 1 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 4.501521e-07 | 6.347 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 4.393644e-07 | 6.357 | 1 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 1.747858e-06 | 5.757 | 1 | 1 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 2.087723e-06 | 5.680 | 1 | 1 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 3.602714e-06 | 5.443 | 1 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 6.226737e-06 | 5.206 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 1.220965e-05 | 4.913 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.168194e-05 | 4.932 | 1 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.608474e-05 | 4.794 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 2.677037e-05 | 4.572 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 2.677037e-05 | 4.572 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.918865e-05 | 4.535 | 1 | 1 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 4.212277e-05 | 4.375 | 1 | 1 |
| HDACs deacetylate histones | R-HSA-3214815 | 5.762614e-05 | 4.239 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 5.604732e-05 | 4.251 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 5.428666e-05 | 4.265 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 7.630662e-05 | 4.117 | 1 | 1 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 8.733446e-05 | 4.059 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.103119e-04 | 3.957 | 1 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.103119e-04 | 3.957 | 1 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.080458e-04 | 3.966 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 1.189547e-04 | 3.925 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.172355e-04 | 3.931 | 1 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 1.281265e-04 | 3.892 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 1.458041e-04 | 3.836 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 1.691768e-04 | 3.772 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.827482e-04 | 3.738 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.955989e-04 | 3.709 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.937816e-04 | 3.713 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.091524e-04 | 3.680 | 1 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 2.279694e-04 | 3.642 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.754343e-04 | 3.560 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.783322e-04 | 3.555 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 3.343741e-04 | 3.476 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 3.462512e-04 | 3.461 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 3.789104e-04 | 3.421 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 3.913356e-04 | 3.407 | 1 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 3.766185e-04 | 3.424 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 4.503290e-04 | 3.346 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 4.780850e-04 | 3.320 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 4.808183e-04 | 3.318 | 1 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 5.261728e-04 | 3.279 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 5.261728e-04 | 3.279 | 1 | 1 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 5.261728e-04 | 3.279 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 5.496987e-04 | 3.260 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 6.620909e-04 | 3.179 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 7.766865e-04 | 3.110 | 1 | 1 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 8.322493e-04 | 3.080 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 7.856017e-04 | 3.105 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 9.688409e-04 | 3.014 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 9.688409e-04 | 3.014 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 9.302450e-04 | 3.031 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 9.285246e-04 | 3.032 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 9.402088e-04 | 3.027 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.053455e-03 | 2.977 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.199713e-03 | 2.921 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.256744e-03 | 2.901 | 0 | 0 |
| TRKA activation by NGF | R-HSA-187042 | 1.291569e-03 | 2.889 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.501022e-03 | 2.824 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 1.677533e-03 | 2.775 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.699222e-03 | 2.770 | 1 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 1.847254e-03 | 2.733 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.847254e-03 | 2.733 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.963419e-03 | 2.707 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.999526e-03 | 2.699 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.137433e-03 | 2.670 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 2.238025e-03 | 2.650 | 1 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.245375e-03 | 2.649 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 2.396041e-03 | 2.621 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.431166e-03 | 2.614 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 2.927709e-03 | 2.533 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.927709e-03 | 2.533 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.915865e-03 | 2.535 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 2.927709e-03 | 2.533 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 2.987646e-03 | 2.525 | 1 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 3.198352e-03 | 2.495 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 3.239698e-03 | 2.489 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 3.239698e-03 | 2.489 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.573419e-03 | 2.447 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 3.926295e-03 | 2.406 | 1 | 1 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 3.722221e-03 | 2.429 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 3.573419e-03 | 2.447 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 3.827188e-03 | 2.417 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 3.621767e-03 | 2.441 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 3.926295e-03 | 2.406 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 4.993840e-03 | 2.302 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 4.993840e-03 | 2.302 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 5.023380e-03 | 2.299 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 5.109260e-03 | 2.292 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 5.109260e-03 | 2.292 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 5.109260e-03 | 2.292 | 0 | 0 |
| Drug resistance of FLT3 mutants | R-HSA-9702506 | 1.031747e-02 | 1.986 | 0 | 0 |
| Drug resistance of KIT mutants | R-HSA-9669937 | 1.031747e-02 | 1.986 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.031747e-02 | 1.986 | 0 | 0 |
| KIT mutants bind TKIs | R-HSA-9669921 | 1.031747e-02 | 1.986 | 0 | 0 |
| FLT3 mutants bind TKIs | R-HSA-9702509 | 1.031747e-02 | 1.986 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.031747e-02 | 1.986 | 0 | 0 |
| crenolanib-resistant FLT3 mutants | R-HSA-9702581 | 1.031747e-02 | 1.986 | 0 | 0 |
| KW2449-resistant FLT3 mutants | R-HSA-9702569 | 1.031747e-02 | 1.986 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.031747e-02 | 1.986 | 0 | 0 |
| Masitinib-resistant KIT mutants | R-HSA-9669924 | 1.031747e-02 | 1.986 | 0 | 0 |
| tamatinib-resistant FLT3 mutants | R-HSA-9703009 | 1.031747e-02 | 1.986 | 0 | 0 |
| ponatinib-resistant FLT3 mutants | R-HSA-9702614 | 1.031747e-02 | 1.986 | 0 | 0 |
| Sorafenib-resistant KIT mutants | R-HSA-9669936 | 1.031747e-02 | 1.986 | 0 | 0 |
| pexidartinib-resistant FLT3 mutants | R-HSA-9702605 | 1.031747e-02 | 1.986 | 0 | 0 |
| sorafenib-resistant FLT3 mutants | R-HSA-9702624 | 1.031747e-02 | 1.986 | 0 | 0 |
| gilteritinib-resistant FLT3 mutants | R-HSA-9702590 | 1.031747e-02 | 1.986 | 0 | 0 |
| Dasatinib-resistant KIT mutants | R-HSA-9669914 | 1.031747e-02 | 1.986 | 0 | 0 |
| sunitinib-resistant FLT3 mutants | R-HSA-9702632 | 1.031747e-02 | 1.986 | 0 | 0 |
| lestaurtinib-resistant FLT3 mutants | R-HSA-9702596 | 1.031747e-02 | 1.986 | 0 | 0 |
| linifanib-resistant FLT3 mutants | R-HSA-9702998 | 1.031747e-02 | 1.986 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.031747e-02 | 1.986 | 0 | 0 |
| semaxanib-resistant FLT3 mutants | R-HSA-9702577 | 1.031747e-02 | 1.986 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.031747e-02 | 1.986 | 0 | 0 |
| Sunitinib-resistant KIT mutants | R-HSA-9669934 | 1.031747e-02 | 1.986 | 0 | 0 |
| quizartinib-resistant FLT3 mutants | R-HSA-9702620 | 1.031747e-02 | 1.986 | 0 | 0 |
| Imatinib-resistant KIT mutants | R-HSA-9669917 | 1.031747e-02 | 1.986 | 0 | 0 |
| midostaurin-resistant FLT3 mutants | R-HSA-9702600 | 1.031747e-02 | 1.986 | 0 | 0 |
| Regorafenib-resistant KIT mutants | R-HSA-9669929 | 1.031747e-02 | 1.986 | 0 | 0 |
| tandutinib-resistant FLT3 mutants | R-HSA-9702636 | 1.031747e-02 | 1.986 | 0 | 0 |
| Nilotinib-resistant KIT mutants | R-HSA-9669926 | 1.031747e-02 | 1.986 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.031747e-02 | 1.986 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 6.001761e-03 | 2.222 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 6.001761e-03 | 2.222 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 7.094421e-03 | 2.149 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 8.269985e-03 | 2.082 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 9.526648e-03 | 2.021 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 6.004727e-03 | 2.222 | 1 | 1 |
| DNA methylation | R-HSA-5334118 | 6.004727e-03 | 2.222 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 6.485381e-03 | 2.188 | 1 | 0 |
| Downstream signal transduction | R-HSA-186763 | 6.988335e-03 | 2.156 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 5.763045e-03 | 2.239 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 8.440438e-03 | 2.074 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 6.485381e-03 | 2.188 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 5.474685e-03 | 2.262 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 6.001761e-03 | 2.222 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 8.068443e-03 | 2.093 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 9.227814e-03 | 2.035 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.004029e-02 | 1.998 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 9.845640e-03 | 2.007 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 8.269985e-03 | 2.082 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 9.227814e-03 | 2.035 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 8.269985e-03 | 2.082 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 7.094421e-03 | 2.149 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 8.269985e-03 | 2.082 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 7.513833e-03 | 2.124 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 8.062105e-03 | 2.094 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 6.555401e-03 | 2.183 | 1 | 1 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 7.016724e-03 | 2.154 | 1 | 0 |
| Disease | R-HSA-1643685 | 6.042918e-03 | 2.219 | 1 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 6.369788e-03 | 2.196 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 8.382812e-03 | 2.077 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 8.382812e-03 | 2.077 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.227814e-03 | 2.035 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 5.474685e-03 | 2.262 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.048702e-02 | 1.979 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 1.086263e-02 | 1.964 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.115210e-02 | 1.953 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 1.115210e-02 | 1.953 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 1.115210e-02 | 1.953 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.182492e-02 | 1.927 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.182492e-02 | 1.927 | 0 | 0 |
| Depurination | R-HSA-73927 | 1.184105e-02 | 1.927 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 1.227618e-02 | 1.911 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.227618e-02 | 1.911 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 1.227618e-02 | 1.911 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.227618e-02 | 1.911 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.255398e-02 | 1.901 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.278880e-02 | 1.893 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.329103e-02 | 1.876 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.329103e-02 | 1.876 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 1.532914e-02 | 1.814 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.532914e-02 | 1.814 | 1 | 1 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.696517e-02 | 1.770 | 1 | 1 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.483791e-02 | 1.829 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.696517e-02 | 1.770 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.483791e-02 | 1.829 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 1.376558e-02 | 1.861 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 1.376558e-02 | 1.861 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 1.532914e-02 | 1.814 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.597646e-02 | 1.797 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.405231e-02 | 1.852 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 1.734148e-02 | 1.761 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.727664e-02 | 1.763 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.486380e-02 | 1.828 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.648243e-02 | 1.783 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.734148e-02 | 1.761 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.551427e-02 | 1.809 | 1 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.740091e-02 | 1.759 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 1.564792e-02 | 1.806 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 1.564792e-02 | 1.806 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.600948e-02 | 1.796 | 1 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.774137e-02 | 1.751 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.822515e-02 | 1.739 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.822515e-02 | 1.739 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.835557e-02 | 1.736 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.861083e-02 | 1.730 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.867204e-02 | 1.729 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.867204e-02 | 1.729 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.913347e-02 | 1.718 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.913347e-02 | 1.718 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.913347e-02 | 1.718 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.913347e-02 | 1.718 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.913347e-02 | 1.718 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 2.052911e-02 | 1.688 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 2.094384e-02 | 1.679 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.094384e-02 | 1.679 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 2.102421e-02 | 1.677 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.162412e-02 | 1.665 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.229185e-02 | 1.652 | 1 | 1 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.229185e-02 | 1.652 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.229185e-02 | 1.652 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.231780e-02 | 1.651 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.233730e-02 | 1.651 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 2.302494e-02 | 1.638 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 2.398550e-02 | 1.620 | 1 | 0 |
| Meiotic recombination | R-HSA-912446 | 2.404579e-02 | 1.619 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.420163e-02 | 1.616 | 1 | 1 |
| Nephron development | R-HSA-9831926 | 2.420163e-02 | 1.616 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.617593e-02 | 1.582 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 2.617593e-02 | 1.582 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 2.618381e-02 | 1.582 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 2.618381e-02 | 1.582 | 0 | 0 |
| NTRK3 as a dependence receptor | R-HSA-9603505 | 3.063602e-02 | 1.514 | 0 | 0 |
| Signaling by juxtamembrane domain KIT mutants | R-HSA-9669935 | 3.063602e-02 | 1.514 | 0 | 0 |
| Signaling by extracellular domain mutants of KIT | R-HSA-9680187 | 3.063602e-02 | 1.514 | 0 | 0 |
| Signaling by kinase domain mutants of KIT | R-HSA-9669933 | 3.063602e-02 | 1.514 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.063925e-02 | 1.391 | 0 | 0 |
| NTF4 activates NTRK2 (TRKB) signaling | R-HSA-9026357 | 4.063925e-02 | 1.391 | 0 | 0 |
| NTF3 activates NTRK2 (TRKB) signaling | R-HSA-9025046 | 4.063925e-02 | 1.391 | 0 | 0 |
| BDNF activates NTRK2 (TRKB) signaling | R-HSA-9024909 | 4.063925e-02 | 1.391 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.063925e-02 | 1.391 | 0 | 0 |
| NTF3 activates NTRK3 signaling | R-HSA-9034013 | 4.063925e-02 | 1.391 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.063925e-02 | 1.391 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.063925e-02 | 1.391 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.063925e-02 | 1.391 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.063925e-02 | 1.391 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.063925e-02 | 1.391 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.063925e-02 | 1.391 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.063925e-02 | 1.391 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.063925e-02 | 1.391 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.063925e-02 | 1.391 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 3.031204e-02 | 1.518 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 3.247089e-02 | 1.489 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 3.929332e-02 | 1.406 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 3.084776e-02 | 1.511 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 3.468833e-02 | 1.460 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 3.702067e-02 | 1.432 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 3.929332e-02 | 1.406 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.750807e-02 | 1.561 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.821323e-02 | 1.550 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 3.969594e-02 | 1.401 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 3.031204e-02 | 1.518 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 3.368448e-02 | 1.473 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 3.257831e-02 | 1.487 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 3.571912e-02 | 1.447 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 3.468833e-02 | 1.460 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 3.468833e-02 | 1.460 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 3.195994e-02 | 1.495 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.957580e-02 | 1.529 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 3.247089e-02 | 1.489 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 2.728984e-02 | 1.564 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 3.810589e-02 | 1.419 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.821323e-02 | 1.550 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 3.620724e-02 | 1.441 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 3.702067e-02 | 1.432 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 4.049219e-02 | 1.393 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 4.106947e-02 | 1.386 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 4.139035e-02 | 1.383 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 4.167809e-02 | 1.380 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 4.167809e-02 | 1.380 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 4.167809e-02 | 1.380 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 4.167809e-02 | 1.380 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 4.207193e-02 | 1.376 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 4.246262e-02 | 1.372 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 4.246679e-02 | 1.372 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 4.309861e-02 | 1.366 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 4.411589e-02 | 1.355 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 4.411589e-02 | 1.355 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 4.660540e-02 | 1.332 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 4.829147e-02 | 1.316 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 4.980586e-02 | 1.303 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 5.023116e-02 | 1.299 | 1 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 5.053987e-02 | 1.296 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 5.053987e-02 | 1.296 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 5.053987e-02 | 1.296 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 5.053987e-02 | 1.296 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 5.053987e-02 | 1.296 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 5.053987e-02 | 1.296 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 5.173429e-02 | 1.286 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 5.181769e-02 | 1.286 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 5.290354e-02 | 1.277 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 5.297057e-02 | 1.276 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 5.437111e-02 | 1.265 | 1 | 1 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 5.437111e-02 | 1.265 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 5.448653e-02 | 1.264 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 5.705451e-02 | 1.244 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 6.033892e-02 | 1.219 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 6.033892e-02 | 1.219 | 1 | 1 |
| Regulation of gap junction activity | R-HSA-191650 | 6.033892e-02 | 1.219 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 6.033892e-02 | 1.219 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 6.033892e-02 | 1.219 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 6.104254e-02 | 1.214 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 6.255616e-02 | 1.204 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 6.445267e-02 | 1.191 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 6.619016e-02 | 1.179 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 6.619016e-02 | 1.179 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 6.822964e-02 | 1.166 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 6.822964e-02 | 1.166 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 7.003744e-02 | 1.155 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 7.003744e-02 | 1.155 | 0 | 0 |
| IRS activation | R-HSA-74713 | 7.003744e-02 | 1.155 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 7.003744e-02 | 1.155 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 7.003744e-02 | 1.155 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 7.963645e-02 | 1.099 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 7.963645e-02 | 1.099 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 7.963645e-02 | 1.099 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 7.963645e-02 | 1.099 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 8.913696e-02 | 1.050 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 8.913696e-02 | 1.050 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 9.853999e-02 | 1.006 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 9.853999e-02 | 1.006 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 9.853999e-02 | 1.006 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 1.078465e-01 | 0.967 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 1.078465e-01 | 0.967 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 1.078465e-01 | 0.967 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 1.078465e-01 | 0.967 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.170575e-01 | 0.932 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.261740e-01 | 0.899 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.351970e-01 | 0.869 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 8.005528e-02 | 1.097 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.086831e-01 | 0.964 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.187520e-01 | 0.925 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 7.216851e-02 | 1.142 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 8.506783e-02 | 1.070 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 8.930876e-02 | 1.049 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 9.853999e-02 | 1.006 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 1.009343e-01 | 0.996 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 7.335212e-02 | 1.135 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.261740e-01 | 0.899 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.261740e-01 | 0.899 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.065417e-02 | 1.043 | 0 | 0 |
| Signaling by MST1 | R-HSA-8852405 | 7.963645e-02 | 1.099 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 1.078465e-01 | 0.967 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.205370e-01 | 0.919 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.205370e-01 | 0.919 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 9.853999e-02 | 1.006 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 8.913696e-02 | 1.050 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 9.853999e-02 | 1.006 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.618980e-02 | 1.065 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 1.078465e-01 | 0.967 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 7.112790e-02 | 1.148 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.065417e-02 | 1.043 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 1.261740e-01 | 0.899 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 1.261740e-01 | 0.899 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 7.335212e-02 | 1.135 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.138531e-01 | 0.944 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.263718e-02 | 1.083 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.360070e-01 | 0.866 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 1.170575e-01 | 0.932 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 7.406567e-02 | 1.130 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 7.963645e-02 | 1.099 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 9.853999e-02 | 1.006 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 9.246083e-02 | 1.034 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 7.406567e-02 | 1.130 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.021057e-01 | 0.991 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.170575e-01 | 0.932 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 8.618980e-02 | 1.065 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 8.749327e-02 | 1.058 | 1 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 7.963645e-02 | 1.099 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 7.963645e-02 | 1.099 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 1.351970e-01 | 0.869 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.073169e-01 | 0.969 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 8.310496e-02 | 1.080 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 7.112790e-02 | 1.148 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.112790e-02 | 1.148 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.030444e-01 | 0.987 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.383388e-01 | 0.859 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 9.886027e-02 | 1.005 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.053803e-01 | 0.977 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.170887e-01 | 0.931 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.030444e-01 | 0.987 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 1.205370e-01 | 0.919 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.250719e-01 | 0.903 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 8.471008e-02 | 1.072 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.034354e-01 | 0.985 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 1.351970e-01 | 0.869 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.153699e-01 | 0.938 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 7.748464e-02 | 1.111 | 1 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 8.084418e-02 | 1.092 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 8.629723e-02 | 1.064 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 8.034686e-02 | 1.095 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.073169e-01 | 0.969 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.050729e-01 | 0.979 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.384831e-01 | 0.859 | 1 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 1.390358e-01 | 0.857 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.401965e-01 | 0.853 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 1.430697e-01 | 0.844 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.438041e-01 | 0.842 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.466257e-01 | 0.834 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 1.510568e-01 | 0.821 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 1.529659e-01 | 0.815 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 1.529659e-01 | 0.815 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 1.529659e-01 | 0.815 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.529659e-01 | 0.815 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.529659e-01 | 0.815 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 1.529659e-01 | 0.815 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.573998e-01 | 0.803 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.584244e-01 | 0.800 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.589204e-01 | 0.799 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 1.617138e-01 | 0.791 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.617138e-01 | 0.791 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.617138e-01 | 0.791 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.659008e-01 | 0.780 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.703719e-01 | 0.769 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 1.703719e-01 | 0.769 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.703719e-01 | 0.769 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.709424e-01 | 0.767 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.756670e-01 | 0.755 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.785864e-01 | 0.748 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.785864e-01 | 0.748 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.785864e-01 | 0.748 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.789410e-01 | 0.747 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 1.789410e-01 | 0.747 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 1.789410e-01 | 0.747 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 1.789410e-01 | 0.747 | 1 | 1 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.789410e-01 | 0.747 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.789410e-01 | 0.747 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.789410e-01 | 0.747 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.789410e-01 | 0.747 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.789410e-01 | 0.747 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.789410e-01 | 0.747 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 1.830665e-01 | 0.737 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 1.837343e-01 | 0.736 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.837343e-01 | 0.736 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.874223e-01 | 0.727 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.874223e-01 | 0.727 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 1.874223e-01 | 0.727 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 1.874223e-01 | 0.727 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 1.874223e-01 | 0.727 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 1.874223e-01 | 0.727 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 1.874223e-01 | 0.727 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.905110e-01 | 0.720 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.938095e-01 | 0.713 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.941463e-01 | 0.712 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 1.958164e-01 | 0.708 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 1.958164e-01 | 0.708 | 1 | 1 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 1.958164e-01 | 0.708 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 1.958164e-01 | 0.708 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 1.958164e-01 | 0.708 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.004847e-01 | 0.698 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 2.020503e-01 | 0.695 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 2.041243e-01 | 0.690 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 2.041243e-01 | 0.690 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.041243e-01 | 0.690 | 1 | 1 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.041243e-01 | 0.690 | 1 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 2.041243e-01 | 0.690 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 2.092880e-01 | 0.679 | 1 | 1 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.123469e-01 | 0.673 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.123469e-01 | 0.673 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 2.123469e-01 | 0.673 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.123469e-01 | 0.673 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.123469e-01 | 0.673 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 2.123469e-01 | 0.673 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 2.130672e-01 | 0.671 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 2.204850e-01 | 0.657 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.204850e-01 | 0.657 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.204850e-01 | 0.657 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 2.234781e-01 | 0.651 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 2.234781e-01 | 0.651 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 2.234781e-01 | 0.651 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 2.244421e-01 | 0.649 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 2.244421e-01 | 0.649 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 2.261887e-01 | 0.646 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.285396e-01 | 0.641 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.285396e-01 | 0.641 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.285396e-01 | 0.641 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 2.285396e-01 | 0.641 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 2.316289e-01 | 0.635 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.320515e-01 | 0.634 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 2.320515e-01 | 0.634 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 2.365114e-01 | 0.626 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.365114e-01 | 0.626 | 1 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.365114e-01 | 0.626 | 1 | 1 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 2.365114e-01 | 0.626 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 2.365114e-01 | 0.626 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.423939e-01 | 0.615 | 1 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.444014e-01 | 0.612 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 2.444014e-01 | 0.612 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.444014e-01 | 0.612 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 2.508494e-01 | 0.601 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 2.522103e-01 | 0.598 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 2.522103e-01 | 0.598 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 2.591605e-01 | 0.586 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 2.599389e-01 | 0.585 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.599389e-01 | 0.585 | 1 | 1 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 2.647220e-01 | 0.577 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 2.664398e-01 | 0.574 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 2.675882e-01 | 0.573 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 2.675882e-01 | 0.573 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.675882e-01 | 0.573 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 2.751588e-01 | 0.560 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 2.751588e-01 | 0.560 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 2.776696e-01 | 0.556 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 2.779181e-01 | 0.556 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.826517e-01 | 0.549 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.826517e-01 | 0.549 | 1 | 0 |
| TRP channels | R-HSA-3295583 | 2.826517e-01 | 0.549 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 2.845603e-01 | 0.546 | 1 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 2.855651e-01 | 0.544 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 2.893858e-01 | 0.539 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 2.900676e-01 | 0.538 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 2.900676e-01 | 0.538 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 2.900676e-01 | 0.538 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 2.974073e-01 | 0.527 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 3.046422e-01 | 0.516 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.046715e-01 | 0.516 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.046715e-01 | 0.516 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 3.046715e-01 | 0.516 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.118611e-01 | 0.506 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 3.122497e-01 | 0.505 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 3.122497e-01 | 0.505 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 3.148704e-01 | 0.502 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 3.152724e-01 | 0.501 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 3.152724e-01 | 0.501 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 3.189767e-01 | 0.496 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 3.189767e-01 | 0.496 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 3.189767e-01 | 0.496 | 1 | 1 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 3.216833e-01 | 0.493 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 3.237431e-01 | 0.490 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 3.260193e-01 | 0.487 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 3.260193e-01 | 0.487 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.260193e-01 | 0.487 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 3.265671e-01 | 0.486 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 3.329894e-01 | 0.478 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 3.329894e-01 | 0.478 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.329894e-01 | 0.478 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.329894e-01 | 0.478 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.329894e-01 | 0.478 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 3.369671e-01 | 0.472 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 3.398879e-01 | 0.469 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 3.398879e-01 | 0.469 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 3.462335e-01 | 0.461 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 3.467155e-01 | 0.460 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 3.467155e-01 | 0.460 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 3.491473e-01 | 0.457 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 3.534728e-01 | 0.452 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 3.537164e-01 | 0.451 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 3.594667e-01 | 0.444 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.601607e-01 | 0.444 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 3.601607e-01 | 0.444 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 3.601607e-01 | 0.444 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 3.611694e-01 | 0.442 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 3.667798e-01 | 0.436 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 3.667798e-01 | 0.436 | 0 | 0 |
| Immune System | R-HSA-168256 | 3.693710e-01 | 0.433 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 3.744581e-01 | 0.427 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 3.796597e-01 | 0.421 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 3.798145e-01 | 0.420 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 3.798145e-01 | 0.420 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 3.856517e-01 | 0.414 | 1 | 1 |
| Attenuation phase | R-HSA-3371568 | 3.862315e-01 | 0.413 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 3.869942e-01 | 0.412 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 3.925825e-01 | 0.406 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 3.925825e-01 | 0.406 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 3.925825e-01 | 0.406 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 3.988681e-01 | 0.399 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 4.050891e-01 | 0.392 | 0 | 0 |
| M Phase | R-HSA-68886 | 4.066027e-01 | 0.391 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 4.080140e-01 | 0.389 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 4.112461e-01 | 0.386 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 4.198495e-01 | 0.377 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 4.233707e-01 | 0.373 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 4.293396e-01 | 0.367 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 4.293396e-01 | 0.367 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 4.293396e-01 | 0.367 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 4.326286e-01 | 0.364 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 4.352471e-01 | 0.361 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 4.352471e-01 | 0.361 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 4.352471e-01 | 0.361 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 4.468803e-01 | 0.350 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 4.526072e-01 | 0.344 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 4.526072e-01 | 0.344 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 4.582752e-01 | 0.339 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 4.582752e-01 | 0.339 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 4.582752e-01 | 0.339 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 4.638849e-01 | 0.334 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 4.638849e-01 | 0.334 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 4.646130e-01 | 0.333 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.694368e-01 | 0.328 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 4.749316e-01 | 0.323 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 4.749316e-01 | 0.323 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.749316e-01 | 0.323 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 4.784232e-01 | 0.320 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 4.803698e-01 | 0.318 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 4.803698e-01 | 0.318 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 4.817759e-01 | 0.317 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 4.857520e-01 | 0.314 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 4.857520e-01 | 0.314 | 1 | 1 |
| TNF signaling | R-HSA-75893 | 4.857520e-01 | 0.314 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 4.910788e-01 | 0.309 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 4.910788e-01 | 0.309 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 4.910788e-01 | 0.309 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 4.947693e-01 | 0.306 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 4.963508e-01 | 0.304 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 4.963508e-01 | 0.304 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 5.015684e-01 | 0.300 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 5.015684e-01 | 0.300 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 5.118431e-01 | 0.291 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 5.169012e-01 | 0.287 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 5.169012e-01 | 0.287 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.169012e-01 | 0.287 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 5.219072e-01 | 0.282 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 5.219072e-01 | 0.282 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.268617e-01 | 0.278 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 5.317651e-01 | 0.274 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 5.321830e-01 | 0.274 | 1 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 5.366179e-01 | 0.270 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 5.402777e-01 | 0.267 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 5.414208e-01 | 0.266 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 5.428916e-01 | 0.265 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 5.459679e-01 | 0.263 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 5.490298e-01 | 0.260 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 5.518975e-01 | 0.258 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 5.555346e-01 | 0.255 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 5.555346e-01 | 0.255 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 5.555346e-01 | 0.255 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.601426e-01 | 0.252 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.601426e-01 | 0.252 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.647030e-01 | 0.248 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 5.692165e-01 | 0.245 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 5.692165e-01 | 0.245 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 5.736835e-01 | 0.241 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 5.781044e-01 | 0.238 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 5.781044e-01 | 0.238 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 5.781044e-01 | 0.238 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 5.824797e-01 | 0.235 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 5.846430e-01 | 0.233 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 5.849171e-01 | 0.233 | 1 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 5.868099e-01 | 0.232 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 5.910955e-01 | 0.228 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 5.910955e-01 | 0.228 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 5.988618e-01 | 0.223 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 5.995345e-01 | 0.222 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 6.057668e-01 | 0.218 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 6.057668e-01 | 0.218 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 6.158967e-01 | 0.210 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 6.198824e-01 | 0.208 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 6.238269e-01 | 0.205 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 6.288555e-01 | 0.201 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 6.341192e-01 | 0.198 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 6.341192e-01 | 0.198 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 6.349315e-01 | 0.197 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 6.354180e-01 | 0.197 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 6.367292e-01 | 0.196 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 6.429474e-01 | 0.192 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 6.503222e-01 | 0.187 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 6.575457e-01 | 0.182 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 6.646207e-01 | 0.177 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 6.677326e-01 | 0.175 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 6.681036e-01 | 0.175 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 6.681036e-01 | 0.175 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 6.715505e-01 | 0.173 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 6.783379e-01 | 0.169 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 6.783379e-01 | 0.169 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 6.783379e-01 | 0.169 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 6.882585e-01 | 0.162 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 6.882585e-01 | 0.162 | 0 | 0 |
| Translation | R-HSA-72766 | 6.888280e-01 | 0.162 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 6.914973e-01 | 0.160 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 6.947026e-01 | 0.158 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 6.950813e-01 | 0.158 | 1 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 6.978748e-01 | 0.156 | 1 | 1 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 6.978748e-01 | 0.156 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 7.041214e-01 | 0.152 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 7.102395e-01 | 0.149 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 7.102395e-01 | 0.149 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 7.132512e-01 | 0.147 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 7.132512e-01 | 0.147 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 7.132512e-01 | 0.147 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 7.162318e-01 | 0.145 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 7.191817e-01 | 0.143 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 7.191817e-01 | 0.143 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 7.221010e-01 | 0.141 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 7.249902e-01 | 0.140 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 7.249902e-01 | 0.140 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 7.278495e-01 | 0.138 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 7.331232e-01 | 0.135 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 7.362513e-01 | 0.133 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 7.376306e-01 | 0.132 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 7.389942e-01 | 0.131 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 7.417088e-01 | 0.130 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 7.417088e-01 | 0.130 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 7.417088e-01 | 0.130 | 1 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 7.496852e-01 | 0.125 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 7.496852e-01 | 0.125 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 7.496852e-01 | 0.125 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 7.574167e-01 | 0.121 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 7.574167e-01 | 0.121 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 7.599408e-01 | 0.119 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 7.624387e-01 | 0.118 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 7.624387e-01 | 0.118 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 7.697786e-01 | 0.114 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 7.860400e-01 | 0.105 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 7.860400e-01 | 0.105 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 7.920946e-01 | 0.101 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 7.952029e-01 | 0.100 | 1 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 7.969512e-01 | 0.099 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 8.016081e-01 | 0.096 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 8.132700e-01 | 0.090 | 1 | 1 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 8.152160e-01 | 0.089 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 8.190476e-01 | 0.087 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 8.209337e-01 | 0.086 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 8.209337e-01 | 0.086 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.224616e-01 | 0.085 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 8.228002e-01 | 0.085 | 0 | 0 |
| S Phase | R-HSA-69242 | 8.228002e-01 | 0.085 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 8.264755e-01 | 0.083 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 8.300749e-01 | 0.081 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 8.300749e-01 | 0.081 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 8.318467e-01 | 0.080 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 8.336002e-01 | 0.079 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 8.353354e-01 | 0.078 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 8.370527e-01 | 0.077 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.404340e-01 | 0.075 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 8.501652e-01 | 0.070 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 8.650900e-01 | 0.063 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 8.650900e-01 | 0.063 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 8.733255e-01 | 0.059 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 8.850122e-01 | 0.053 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 8.871474e-01 | 0.052 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 8.883270e-01 | 0.051 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 8.906495e-01 | 0.050 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 8.984067e-01 | 0.047 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.005207e-01 | 0.046 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 9.015613e-01 | 0.045 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.056165e-01 | 0.043 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.113901e-01 | 0.040 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 9.150427e-01 | 0.039 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 9.159322e-01 | 0.038 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 9.193861e-01 | 0.037 | 1 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.239206e-01 | 0.034 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 9.243336e-01 | 0.034 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.259109e-01 | 0.033 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.325601e-01 | 0.030 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.348246e-01 | 0.029 | 1 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.515423e-01 | 0.022 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.594319e-01 | 0.018 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.630857e-01 | 0.016 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 9.716693e-01 | 0.012 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.725556e-01 | 0.012 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.888769e-01 | 0.005 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.905204e-01 | 0.004 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.927469e-01 | 0.003 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.988431e-01 | 0.001 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.993854e-01 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 9.999987e-01 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | 0.000 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 1.000000e+00 | 0.000 | 1 | 1 |
| GAB1 signalosome | R-HSA-180292 | 1.000000e+00 | 0.000 | 1 | 1 |
| EGFR downregulation | R-HSA-182971 | 1.000000e+00 | 0.000 | 1 | 1 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 1.000000e+00 | 0.000 | 1 | 1 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 1.000000e+00 | 0.000 | 1 | 1 |
| Signal transduction by L1 | R-HSA-445144 | 1.000000e+00 | 0.000 | 1 | 1 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 1.000000e+00 | 0.000 | 1 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 1.000000e+00 | 0.000 | 1 | 1 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 1.000000e+00 | 0.000 | 1 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 1.000000e+00 | 0.000 | 1 | 1 |
| Signaling by NOTCH3 | R-HSA-9012852 | 1.000000e+00 | 0.000 | 1 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 1.000000e+00 | 0.000 | 1 | 1 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cellular response to heat stress | R-HSA-3371556 | 3.388478e-11 | 10.470 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.564352e-10 | 9.806 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.349049e-10 | 9.870 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.062146e-09 | 8.974 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.516386e-09 | 8.819 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.360456e-09 | 8.866 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 2.272208e-09 | 8.644 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 2.272208e-09 | 8.644 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.272208e-09 | 8.644 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 5.446409e-09 | 8.264 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.707909e-07 | 6.768 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 1.887577e-07 | 6.724 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.180808e-07 | 6.661 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.117544e-07 | 6.674 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 3.798332e-07 | 6.420 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 4.295934e-07 | 6.367 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 4.704488e-07 | 6.327 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 5.513056e-07 | 6.259 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 6.137176e-07 | 6.212 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 9.498717e-07 | 6.022 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.300702e-06 | 5.886 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 2.175220e-06 | 5.662 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 3.737320e-06 | 5.427 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 3.723003e-06 | 5.429 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 4.129622e-06 | 5.384 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 6.717516e-06 | 5.173 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 8.222540e-06 | 5.085 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.402653e-05 | 4.853 | 1 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.812187e-05 | 4.742 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.520454e-05 | 4.599 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 3.105362e-05 | 4.508 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 3.105362e-05 | 4.508 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 3.105362e-05 | 4.508 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 3.105362e-05 | 4.508 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 3.111795e-05 | 4.507 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 3.312012e-05 | 4.480 | 1 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 3.587569e-05 | 4.445 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 7.325856e-05 | 4.135 | 1 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.067947e-04 | 3.971 | 1 | 1 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.067947e-04 | 3.971 | 1 | 0 |
| Cell junction organization | R-HSA-446728 | 1.108468e-04 | 3.955 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 1.146224e-04 | 3.941 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.265109e-04 | 3.898 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.265109e-04 | 3.898 | 1 | 1 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.302401e-04 | 3.885 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.379972e-04 | 3.860 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.481890e-04 | 3.829 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.601664e-04 | 3.795 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.962081e-04 | 3.707 | 1 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.897941e-04 | 3.722 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.014604e-04 | 3.696 | 1 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.014604e-04 | 3.696 | 1 | 1 |
| Cell-cell junction organization | R-HSA-421270 | 2.004064e-04 | 3.698 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 2.121499e-04 | 3.673 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.136264e-04 | 3.670 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 2.440855e-04 | 3.612 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 2.832954e-04 | 3.548 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 2.940867e-04 | 3.532 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.982024e-04 | 3.525 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 3.602976e-04 | 3.443 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 3.613661e-04 | 3.442 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 4.095047e-04 | 3.388 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 4.396299e-04 | 3.357 | 1 | 0 |
| Developmental Biology | R-HSA-1266738 | 5.335662e-04 | 3.273 | 1 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 5.361224e-04 | 3.271 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 5.738664e-04 | 3.241 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 5.869818e-04 | 3.231 | 1 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 6.135798e-04 | 3.212 | 1 | 1 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 6.135798e-04 | 3.212 | 1 | 1 |
| DAP12 signaling | R-HSA-2424491 | 6.810543e-04 | 3.167 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 6.810543e-04 | 3.167 | 1 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 7.132310e-04 | 3.147 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 9.026565e-04 | 3.044 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 9.026565e-04 | 3.044 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 9.026565e-04 | 3.044 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 9.026565e-04 | 3.044 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 9.026565e-04 | 3.044 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 9.026565e-04 | 3.044 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 9.026565e-04 | 3.044 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 9.026565e-04 | 3.044 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 9.026565e-04 | 3.044 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 9.026565e-04 | 3.044 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 9.026565e-04 | 3.044 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 7.920603e-04 | 3.101 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 8.872411e-04 | 3.052 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 7.455654e-04 | 3.128 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 8.830034e-04 | 3.054 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 7.778244e-04 | 3.109 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 9.782369e-04 | 3.010 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 9.998678e-04 | 3.000 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.016962e-03 | 2.993 | 1 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.044920e-03 | 2.981 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 1.044920e-03 | 2.981 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 1.219268e-03 | 2.914 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 1.219268e-03 | 2.914 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.128417e-03 | 2.948 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.128417e-03 | 2.948 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.219268e-03 | 2.914 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.219268e-03 | 2.914 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.219268e-03 | 2.914 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.071780e-03 | 2.970 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.259953e-03 | 2.900 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.259953e-03 | 2.900 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.352446e-03 | 2.869 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.708671e-03 | 2.767 | 1 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.095701e-03 | 2.679 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.000994e-03 | 2.699 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.947627e-03 | 2.710 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.997991e-03 | 2.699 | 1 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.848367e-03 | 2.733 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.851326e-03 | 2.733 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.796472e-03 | 2.746 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.130892e-03 | 2.671 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.222033e-03 | 2.653 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.324589e-03 | 2.634 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 2.517053e-03 | 2.599 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.531856e-03 | 2.597 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 2.594875e-03 | 2.586 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 2.649294e-03 | 2.577 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.649294e-03 | 2.577 | 1 | 1 |
| PKR-mediated signaling | R-HSA-9833482 | 2.851925e-03 | 2.545 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.863960e-03 | 2.543 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 3.171533e-03 | 2.499 | 1 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 3.285283e-03 | 2.483 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 3.376271e-03 | 2.472 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 3.441694e-03 | 2.463 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 3.489898e-03 | 2.457 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 3.509743e-03 | 2.455 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.401649e-03 | 2.356 | 1 | 1 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 4.995748e-03 | 2.301 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 4.410727e-03 | 2.355 | 0 | 0 |
| Immune System | R-HSA-168256 | 5.274532e-03 | 2.278 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 5.407015e-03 | 2.267 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 5.407015e-03 | 2.267 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 6.496479e-03 | 2.187 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 6.646431e-03 | 2.177 | 1 | 1 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 6.826339e-03 | 2.166 | 1 | 1 |
| FOXO-mediated transcription | R-HSA-9614085 | 7.210603e-03 | 2.142 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 7.300514e-03 | 2.137 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 7.341321e-03 | 2.134 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 7.480312e-03 | 2.126 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 7.676812e-03 | 2.115 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 7.677025e-03 | 2.115 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 7.677025e-03 | 2.115 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 7.677025e-03 | 2.115 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 7.756978e-03 | 2.110 | 1 | 1 |
| Disease | R-HSA-1643685 | 7.778828e-03 | 2.109 | 1 | 0 |
| Downstream signal transduction | R-HSA-186763 | 7.817173e-03 | 2.107 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 7.839401e-03 | 2.106 | 1 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 8.891944e-03 | 2.051 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.030936e-02 | 1.987 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.023117e-02 | 1.990 | 1 | 0 |
| eNOS activation | R-HSA-203615 | 1.030936e-02 | 1.987 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 8.946591e-03 | 2.048 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 8.271739e-03 | 2.082 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 9.012650e-03 | 2.045 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.074760e-02 | 1.969 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.074760e-02 | 1.969 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.074760e-02 | 1.969 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.074760e-02 | 1.969 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.074760e-02 | 1.969 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.074760e-02 | 1.969 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 1.099617e-02 | 1.959 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.147829e-02 | 1.940 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.153363e-02 | 1.938 | 1 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.153363e-02 | 1.938 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 1.170884e-02 | 1.931 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.211433e-02 | 1.917 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.220127e-02 | 1.914 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 1.321241e-02 | 1.879 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.321241e-02 | 1.879 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 1.326930e-02 | 1.877 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 1.400357e-02 | 1.854 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.417954e-02 | 1.848 | 1 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.444784e-02 | 1.840 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.482113e-02 | 1.829 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.581290e-02 | 1.801 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 1.581290e-02 | 1.801 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.655991e-02 | 1.781 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 1.655991e-02 | 1.781 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.669706e-02 | 1.777 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.743318e-02 | 1.759 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.832216e-02 | 1.737 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.015992e-02 | 1.696 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.405473e-02 | 1.619 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.207137e-02 | 1.656 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.232147e-02 | 1.651 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.930804e-02 | 1.714 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.903844e-02 | 1.720 | 1 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 2.446469e-02 | 1.611 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.168602e-02 | 1.664 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.246706e-02 | 1.648 | 1 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.835722e-02 | 1.736 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.405473e-02 | 1.619 | 0 | 0 |
| Protein folding | R-HSA-391251 | 2.545485e-02 | 1.594 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 2.610827e-02 | 1.583 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.647402e-02 | 1.577 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 2.670674e-02 | 1.573 | 1 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 2.823027e-02 | 1.549 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.823027e-02 | 1.549 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 2.867771e-02 | 1.542 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 2.867771e-02 | 1.542 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 2.867771e-02 | 1.542 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 2.889116e-02 | 1.539 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 3.041902e-02 | 1.517 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 3.041902e-02 | 1.517 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 3.135610e-02 | 1.504 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 3.153719e-02 | 1.501 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 3.189947e-02 | 1.496 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 3.189947e-02 | 1.496 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 3.189947e-02 | 1.496 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 3.189947e-02 | 1.496 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 3.189947e-02 | 1.496 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.189947e-02 | 1.496 | 0 | 0 |
| M Phase | R-HSA-68886 | 3.201087e-02 | 1.495 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 3.267287e-02 | 1.486 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.267287e-02 | 1.486 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 3.451890e-02 | 1.462 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 3.499019e-02 | 1.456 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 3.499019e-02 | 1.456 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 3.512940e-02 | 1.454 | 1 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 3.700368e-02 | 1.432 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 4.230615e-02 | 1.374 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 5.260161e-02 | 1.279 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.736936e-02 | 1.427 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 3.980882e-02 | 1.400 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 4.747341e-02 | 1.324 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 5.231594e-02 | 1.281 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 4.320001e-02 | 1.365 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 3.736936e-02 | 1.427 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 4.099358e-02 | 1.387 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 5.285672e-02 | 1.277 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 4.230615e-02 | 1.374 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 4.230615e-02 | 1.374 | 0 | 0 |
| STAT6-mediated induction of chemokines | R-HSA-3249367 | 5.260161e-02 | 1.279 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 5.260161e-02 | 1.279 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 5.013869e-02 | 1.300 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 4.428617e-02 | 1.354 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 5.562610e-02 | 1.255 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 4.486236e-02 | 1.348 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 4.486236e-02 | 1.348 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 4.230615e-02 | 1.374 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 4.230615e-02 | 1.374 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 4.878335e-02 | 1.312 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 4.107348e-02 | 1.386 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 4.623642e-02 | 1.335 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 4.623642e-02 | 1.335 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 3.736936e-02 | 1.427 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 4.230615e-02 | 1.374 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 5.013869e-02 | 1.300 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.562610e-02 | 1.255 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 3.796498e-02 | 1.421 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 5.013869e-02 | 1.300 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 4.538711e-02 | 1.343 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 4.486236e-02 | 1.348 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 4.747341e-02 | 1.324 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 5.013869e-02 | 1.300 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 5.010694e-02 | 1.300 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.980882e-02 | 1.400 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 4.230699e-02 | 1.374 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 3.736936e-02 | 1.427 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 5.013869e-02 | 1.300 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 4.486236e-02 | 1.348 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 5.010694e-02 | 1.300 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 5.203193e-02 | 1.284 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 5.844540e-02 | 1.233 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 5.844540e-02 | 1.233 | 1 | 1 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 5.844540e-02 | 1.233 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 5.846989e-02 | 1.233 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 6.011795e-02 | 1.221 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 6.131326e-02 | 1.212 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 6.131326e-02 | 1.212 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 6.278702e-02 | 1.202 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 6.278702e-02 | 1.202 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 6.422831e-02 | 1.192 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 6.718923e-02 | 1.173 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 6.718923e-02 | 1.173 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 6.911873e-02 | 1.160 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 6.918643e-02 | 1.160 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 7.019471e-02 | 1.154 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 7.286355e-02 | 1.137 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 7.286355e-02 | 1.137 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 7.286355e-02 | 1.137 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 7.286355e-02 | 1.137 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 7.336577e-02 | 1.135 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 7.633420e-02 | 1.117 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.633420e-02 | 1.117 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 7.633420e-02 | 1.117 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 7.929897e-02 | 1.101 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 8.283235e-02 | 1.082 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 9.269458e-02 | 1.033 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.024514e-01 | 0.989 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 1.121038e-01 | 0.950 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.121038e-01 | 0.950 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.121038e-01 | 0.950 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.216531e-01 | 0.915 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.216531e-01 | 0.915 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.311002e-01 | 0.882 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 1.311002e-01 | 0.882 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 1.496924e-01 | 0.825 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.415093e-01 | 0.849 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.216531e-01 | 0.915 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.121038e-01 | 0.950 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.311002e-01 | 0.882 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.404463e-01 | 0.852 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.311002e-01 | 0.882 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 8.909271e-02 | 1.050 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.127643e-01 | 0.948 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 1.024514e-01 | 0.989 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 1.121038e-01 | 0.950 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 1.121038e-01 | 0.950 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.216531e-01 | 0.915 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 1.496924e-01 | 0.825 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.024277e-01 | 0.990 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.944085e-02 | 1.002 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 8.674271e-02 | 1.062 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 1.016266e-01 | 0.993 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 8.283235e-02 | 1.082 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 9.269458e-02 | 1.033 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.588397e-01 | 0.799 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 8.909271e-02 | 1.050 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 8.283235e-02 | 1.082 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.024514e-01 | 0.989 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 1.121038e-01 | 0.950 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 1.121038e-01 | 0.950 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 1.216531e-01 | 0.915 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 1.216531e-01 | 0.915 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 1.404463e-01 | 0.852 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 1.404463e-01 | 0.852 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 8.584616e-02 | 1.066 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 1.245613e-01 | 0.905 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.244965e-01 | 0.905 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 1.515641e-01 | 0.819 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 1.024514e-01 | 0.989 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 1.024514e-01 | 0.989 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.311002e-01 | 0.882 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 1.496924e-01 | 0.825 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 9.237526e-02 | 1.034 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 1.121038e-01 | 0.950 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.216531e-01 | 0.915 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.311002e-01 | 0.882 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 1.496924e-01 | 0.825 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 1.588397e-01 | 0.799 | 1 | 1 |
| IRS-mediated signalling | R-HSA-112399 | 1.564132e-01 | 0.806 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 9.823512e-02 | 1.008 | 1 | 1 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.564132e-01 | 0.806 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 1.588397e-01 | 0.799 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 9.904385e-02 | 1.004 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 9.904385e-02 | 1.004 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 9.269458e-02 | 1.033 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 1.404463e-01 | 0.852 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 1.404463e-01 | 0.852 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 1.496924e-01 | 0.825 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 1.496924e-01 | 0.825 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.496924e-01 | 0.825 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 1.588397e-01 | 0.799 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 1.060553e-01 | 0.974 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.058431e-01 | 0.975 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.127643e-01 | 0.948 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 1.162681e-01 | 0.935 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 1.526588e-01 | 0.816 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 8.283235e-02 | 1.082 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 8.283235e-02 | 1.082 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 9.269458e-02 | 1.033 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 1.216531e-01 | 0.915 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.588397e-01 | 0.799 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.588397e-01 | 0.799 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 1.588397e-01 | 0.799 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.588397e-01 | 0.799 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 8.584616e-02 | 1.066 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.127643e-01 | 0.948 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 1.311002e-01 | 0.882 | 1 | 1 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 1.588397e-01 | 0.799 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 1.105586e-01 | 0.956 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 9.331693e-02 | 1.030 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 1.341794e-01 | 0.872 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.216531e-01 | 0.915 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.404463e-01 | 0.852 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 1.588397e-01 | 0.799 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 1.305481e-01 | 0.884 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.390331e-01 | 0.857 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.390331e-01 | 0.857 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.526588e-01 | 0.816 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.174493e-01 | 0.930 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.564132e-01 | 0.806 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 9.569268e-02 | 1.019 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 7.946571e-02 | 1.100 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.404463e-01 | 0.852 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.230913e-01 | 0.910 | 1 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.121038e-01 | 0.950 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.588397e-01 | 0.799 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.526588e-01 | 0.816 | 1 | 1 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.128377e-01 | 0.948 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.172679e-01 | 0.931 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.101695e-01 | 0.958 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.263228e-01 | 0.899 | 1 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 9.237526e-02 | 1.034 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 1.058431e-01 | 0.975 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.092890e-01 | 0.961 | 1 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.162681e-01 | 0.935 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 8.258209e-02 | 1.083 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.596107e-01 | 0.797 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.639737e-01 | 0.785 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.639737e-01 | 0.785 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.677782e-01 | 0.775 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.677782e-01 | 0.775 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.678891e-01 | 0.775 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.678891e-01 | 0.775 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.678891e-01 | 0.775 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.678891e-01 | 0.775 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 1.678891e-01 | 0.775 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.678891e-01 | 0.775 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 1.715980e-01 | 0.765 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 1.754321e-01 | 0.756 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 1.768417e-01 | 0.752 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.768417e-01 | 0.752 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 1.768417e-01 | 0.752 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.792799e-01 | 0.746 | 1 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.792799e-01 | 0.746 | 1 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 1.800548e-01 | 0.745 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.803014e-01 | 0.744 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 1.831407e-01 | 0.737 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 1.831407e-01 | 0.737 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.856791e-01 | 0.731 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.856985e-01 | 0.731 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.856985e-01 | 0.731 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.856985e-01 | 0.731 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 1.856985e-01 | 0.731 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.856985e-01 | 0.731 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 1.856985e-01 | 0.731 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 1.856985e-01 | 0.731 | 1 | 1 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.856985e-01 | 0.731 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.856985e-01 | 0.731 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 1.856985e-01 | 0.731 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 1.870136e-01 | 0.728 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.870136e-01 | 0.728 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.944606e-01 | 0.711 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 1.944606e-01 | 0.711 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.986989e-01 | 0.702 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.020564e-01 | 0.695 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 2.026139e-01 | 0.693 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 2.031289e-01 | 0.692 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 2.031289e-01 | 0.692 | 1 | 1 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.031289e-01 | 0.692 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 2.031289e-01 | 0.692 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 2.031289e-01 | 0.692 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 2.031289e-01 | 0.692 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.031289e-01 | 0.692 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 2.065376e-01 | 0.685 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.104696e-01 | 0.677 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 2.104696e-01 | 0.677 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 2.104696e-01 | 0.677 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 2.104696e-01 | 0.677 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.117045e-01 | 0.674 | 1 | 1 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 2.117045e-01 | 0.674 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.133767e-01 | 0.671 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 2.144092e-01 | 0.669 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 2.144092e-01 | 0.669 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 2.159546e-01 | 0.666 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.183557e-01 | 0.661 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.201883e-01 | 0.657 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.201883e-01 | 0.657 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 2.201883e-01 | 0.657 | 0 | 0 |
| PKA activation | R-HSA-163615 | 2.201883e-01 | 0.657 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.201883e-01 | 0.657 | 1 | 1 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.201883e-01 | 0.657 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.201883e-01 | 0.657 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.223086e-01 | 0.653 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 2.223086e-01 | 0.653 | 1 | 1 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.262673e-01 | 0.645 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 2.285813e-01 | 0.641 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.285813e-01 | 0.641 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.285813e-01 | 0.641 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.285813e-01 | 0.641 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 2.285813e-01 | 0.641 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 2.285813e-01 | 0.641 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 2.285813e-01 | 0.641 | 1 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.300486e-01 | 0.638 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 2.302311e-01 | 0.638 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 2.302311e-01 | 0.638 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 2.368845e-01 | 0.625 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.368845e-01 | 0.625 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.368845e-01 | 0.625 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 2.381722e-01 | 0.623 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 2.381722e-01 | 0.623 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 2.450989e-01 | 0.611 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 2.450989e-01 | 0.611 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 2.450989e-01 | 0.611 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 2.450989e-01 | 0.611 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 2.450989e-01 | 0.611 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.461274e-01 | 0.609 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.500541e-01 | 0.602 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.524577e-01 | 0.598 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.532253e-01 | 0.596 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.532253e-01 | 0.596 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 2.532253e-01 | 0.596 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 2.532253e-01 | 0.596 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.532253e-01 | 0.596 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.532253e-01 | 0.596 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 2.548042e-01 | 0.594 | 1 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.548045e-01 | 0.594 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 2.603977e-01 | 0.584 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 2.612647e-01 | 0.583 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 2.612647e-01 | 0.583 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.612647e-01 | 0.583 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 2.612647e-01 | 0.583 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 2.645014e-01 | 0.578 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.674038e-01 | 0.573 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 2.692181e-01 | 0.570 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 2.692181e-01 | 0.570 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.692181e-01 | 0.570 | 1 | 1 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 2.692181e-01 | 0.570 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.700367e-01 | 0.569 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.700367e-01 | 0.569 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 2.770864e-01 | 0.557 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 2.770864e-01 | 0.557 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.770864e-01 | 0.557 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 2.770864e-01 | 0.557 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 2.770864e-01 | 0.557 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.770864e-01 | 0.557 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.770864e-01 | 0.557 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 2.780081e-01 | 0.556 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.780081e-01 | 0.556 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.785040e-01 | 0.555 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 2.848704e-01 | 0.545 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.848704e-01 | 0.545 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 2.848704e-01 | 0.545 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 2.848704e-01 | 0.545 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 2.848704e-01 | 0.545 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 2.848704e-01 | 0.545 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 2.848704e-01 | 0.545 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 2.848704e-01 | 0.545 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.848704e-01 | 0.545 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 2.848704e-01 | 0.545 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 2.899544e-01 | 0.538 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.925711e-01 | 0.534 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 2.925711e-01 | 0.534 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 2.936735e-01 | 0.532 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 3.001893e-01 | 0.523 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 3.001893e-01 | 0.523 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 3.001893e-01 | 0.523 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 3.001893e-01 | 0.523 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 3.001893e-01 | 0.523 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 3.018776e-01 | 0.520 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 3.024737e-01 | 0.519 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 3.025442e-01 | 0.519 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 3.077259e-01 | 0.512 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 3.077259e-01 | 0.512 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 3.077259e-01 | 0.512 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 3.077259e-01 | 0.512 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 3.077259e-01 | 0.512 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 3.098082e-01 | 0.509 | 1 | 1 |
| Separation of Sister Chromatids | R-HSA-2467813 | 3.142269e-01 | 0.503 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.151819e-01 | 0.501 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.151819e-01 | 0.501 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.151819e-01 | 0.501 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 3.151819e-01 | 0.501 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 3.225580e-01 | 0.491 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.225580e-01 | 0.491 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 3.225580e-01 | 0.491 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 3.225580e-01 | 0.491 | 1 | 1 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.225580e-01 | 0.491 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 3.298551e-01 | 0.482 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 3.298551e-01 | 0.482 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 3.298551e-01 | 0.482 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 3.298551e-01 | 0.482 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 3.298551e-01 | 0.482 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 3.316850e-01 | 0.479 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 3.370740e-01 | 0.472 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.370740e-01 | 0.472 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.374057e-01 | 0.472 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 3.442157e-01 | 0.463 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 3.442157e-01 | 0.463 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.442157e-01 | 0.463 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 3.442157e-01 | 0.463 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.442157e-01 | 0.463 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 3.442157e-01 | 0.463 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 3.442157e-01 | 0.463 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.442157e-01 | 0.463 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 3.452339e-01 | 0.462 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 3.452339e-01 | 0.462 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 3.512808e-01 | 0.454 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 3.512808e-01 | 0.454 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.512808e-01 | 0.454 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 3.536864e-01 | 0.451 | 1 | 0 |
| RSV-host interactions | R-HSA-9833110 | 3.569197e-01 | 0.447 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 3.582702e-01 | 0.446 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 3.582702e-01 | 0.446 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 3.582702e-01 | 0.446 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 3.582702e-01 | 0.446 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 3.582702e-01 | 0.446 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 3.651848e-01 | 0.437 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 3.651848e-01 | 0.437 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 3.720253e-01 | 0.429 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.720253e-01 | 0.429 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 3.720253e-01 | 0.429 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 3.720253e-01 | 0.429 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 3.720253e-01 | 0.429 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 3.787925e-01 | 0.422 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 3.787925e-01 | 0.422 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.787925e-01 | 0.422 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 3.854872e-01 | 0.414 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 3.854872e-01 | 0.414 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 3.876975e-01 | 0.412 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.921101e-01 | 0.407 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 3.921101e-01 | 0.407 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 3.921101e-01 | 0.407 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 3.921101e-01 | 0.407 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.942119e-01 | 0.404 | 1 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 3.986621e-01 | 0.399 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 3.986621e-01 | 0.399 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 3.986621e-01 | 0.399 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.986621e-01 | 0.399 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 3.986621e-01 | 0.399 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 3.986621e-01 | 0.399 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 3.986621e-01 | 0.399 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 4.051439e-01 | 0.392 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 4.051439e-01 | 0.392 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 4.051439e-01 | 0.392 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 4.051439e-01 | 0.392 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 4.066075e-01 | 0.391 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 4.095493e-01 | 0.388 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 4.106684e-01 | 0.387 | 1 | 1 |
| Intra-Golgi traffic | R-HSA-6811438 | 4.115561e-01 | 0.386 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 4.115561e-01 | 0.386 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 4.178193e-01 | 0.379 | 1 | 0 |
| Ca-dependent events | R-HSA-111996 | 4.178997e-01 | 0.379 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 4.178997e-01 | 0.379 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 4.178997e-01 | 0.379 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 4.241753e-01 | 0.372 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 4.252348e-01 | 0.371 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 4.278540e-01 | 0.369 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 4.303836e-01 | 0.366 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 4.303836e-01 | 0.366 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.303836e-01 | 0.366 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 4.303836e-01 | 0.366 | 0 | 0 |
| Methylation | R-HSA-156581 | 4.303836e-01 | 0.366 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 4.307018e-01 | 0.366 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 4.362658e-01 | 0.360 | 1 | 1 |
| DAG and IP3 signaling | R-HSA-1489509 | 4.365253e-01 | 0.360 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 4.365253e-01 | 0.360 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 4.399176e-01 | 0.357 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 4.399176e-01 | 0.357 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 4.426012e-01 | 0.354 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 4.426012e-01 | 0.354 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 4.426012e-01 | 0.354 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.426012e-01 | 0.354 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 4.433237e-01 | 0.353 | 1 | 1 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 4.486119e-01 | 0.348 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 4.507954e-01 | 0.346 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 4.545582e-01 | 0.342 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 4.545582e-01 | 0.342 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 4.545582e-01 | 0.342 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 4.545582e-01 | 0.342 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 4.588873e-01 | 0.338 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 4.604408e-01 | 0.337 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 4.651125e-01 | 0.332 | 1 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 4.662602e-01 | 0.331 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 4.662602e-01 | 0.331 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 4.662602e-01 | 0.331 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 4.777126e-01 | 0.321 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 4.777126e-01 | 0.321 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 4.777126e-01 | 0.321 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 4.833468e-01 | 0.316 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.833468e-01 | 0.316 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 4.944346e-01 | 0.306 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 4.998894e-01 | 0.301 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 4.998894e-01 | 0.301 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 4.998894e-01 | 0.301 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 5.033269e-01 | 0.298 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 5.087392e-01 | 0.294 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 5.106242e-01 | 0.292 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 5.159053e-01 | 0.287 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 5.186658e-01 | 0.285 | 0 | 0 |
| Kinesins | R-HSA-983189 | 5.211298e-01 | 0.283 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 5.211298e-01 | 0.283 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 5.262982e-01 | 0.279 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 5.262982e-01 | 0.279 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 5.299985e-01 | 0.276 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 5.314112e-01 | 0.275 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 5.314112e-01 | 0.275 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 5.314112e-01 | 0.275 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.314112e-01 | 0.275 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 5.332640e-01 | 0.273 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 5.343541e-01 | 0.272 | 1 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 5.364692e-01 | 0.270 | 0 | 0 |
| Translation | R-HSA-72766 | 5.372518e-01 | 0.270 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 5.414730e-01 | 0.266 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.414730e-01 | 0.266 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 5.414730e-01 | 0.266 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 5.429676e-01 | 0.265 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 5.493590e-01 | 0.260 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 5.525313e-01 | 0.258 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 5.561644e-01 | 0.255 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 5.561644e-01 | 0.255 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 5.561644e-01 | 0.255 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 5.588289e-01 | 0.253 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 5.598534e-01 | 0.252 | 1 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 5.703877e-01 | 0.244 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 5.703877e-01 | 0.244 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 5.747475e-01 | 0.241 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 5.750274e-01 | 0.240 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 5.796172e-01 | 0.237 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 5.841578e-01 | 0.233 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 5.841578e-01 | 0.233 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 5.941159e-01 | 0.226 | 1 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 5.952882e-01 | 0.225 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 5.974889e-01 | 0.224 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 6.018375e-01 | 0.221 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 6.061394e-01 | 0.217 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 6.061394e-01 | 0.217 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 6.098051e-01 | 0.215 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 6.110947e-01 | 0.214 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 6.146050e-01 | 0.211 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 6.146050e-01 | 0.211 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 6.155007e-01 | 0.211 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 6.155007e-01 | 0.211 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 6.187697e-01 | 0.208 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 6.187697e-01 | 0.208 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 6.228896e-01 | 0.206 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 6.228896e-01 | 0.206 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.309972e-01 | 0.200 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 6.322071e-01 | 0.199 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 6.349362e-01 | 0.197 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 6.349858e-01 | 0.197 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 6.349858e-01 | 0.197 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.389315e-01 | 0.195 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 6.389315e-01 | 0.195 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 6.505159e-01 | 0.187 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 6.505159e-01 | 0.187 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 6.580328e-01 | 0.182 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 6.617307e-01 | 0.179 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 6.725877e-01 | 0.172 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 6.761291e-01 | 0.170 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 6.796325e-01 | 0.168 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 6.796325e-01 | 0.168 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 6.862452e-01 | 0.164 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 6.865265e-01 | 0.163 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 6.865265e-01 | 0.163 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 6.865265e-01 | 0.163 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 6.932730e-01 | 0.159 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 6.965919e-01 | 0.157 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 6.998752e-01 | 0.155 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 7.027609e-01 | 0.153 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 7.063360e-01 | 0.151 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 7.095144e-01 | 0.149 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 7.126585e-01 | 0.147 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 7.187228e-01 | 0.143 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 7.188457e-01 | 0.143 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 7.188457e-01 | 0.143 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.218894e-01 | 0.142 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 7.278790e-01 | 0.138 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.278790e-01 | 0.138 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 7.337402e-01 | 0.134 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 7.337402e-01 | 0.134 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 7.478500e-01 | 0.126 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 7.520211e-01 | 0.124 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 7.532834e-01 | 0.123 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 7.586004e-01 | 0.120 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 7.586004e-01 | 0.120 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 7.655602e-01 | 0.116 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 7.688951e-01 | 0.114 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 7.738775e-01 | 0.111 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 7.855458e-01 | 0.105 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 7.950091e-01 | 0.100 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 7.972323e-01 | 0.098 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 7.972323e-01 | 0.098 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 7.991311e-01 | 0.097 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 8.100770e-01 | 0.091 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 8.141761e-01 | 0.089 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 8.141761e-01 | 0.089 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 8.141761e-01 | 0.089 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 8.351983e-01 | 0.078 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 8.369879e-01 | 0.077 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 8.422415e-01 | 0.075 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 8.439550e-01 | 0.074 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.506260e-01 | 0.070 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 8.554425e-01 | 0.068 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 8.598785e-01 | 0.066 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 8.598952e-01 | 0.066 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 8.635957e-01 | 0.064 | 1 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 8.718184e-01 | 0.060 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.718184e-01 | 0.060 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 8.732123e-01 | 0.059 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 8.745912e-01 | 0.058 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 8.825567e-01 | 0.054 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 8.888089e-01 | 0.051 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 8.924001e-01 | 0.049 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 8.947300e-01 | 0.048 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 8.958760e-01 | 0.048 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 8.981311e-01 | 0.047 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.168419e-01 | 0.038 | 1 | 0 |
| DNA Repair | R-HSA-73894 | 9.183744e-01 | 0.037 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.212290e-01 | 0.036 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.250466e-01 | 0.034 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.357197e-01 | 0.029 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.404750e-01 | 0.027 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.419802e-01 | 0.026 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.470245e-01 | 0.024 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.547856e-01 | 0.020 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.573553e-01 | 0.019 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.612331e-01 | 0.017 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.629034e-01 | 0.016 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.678533e-01 | 0.014 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.806517e-01 | 0.008 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.820820e-01 | 0.008 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.879789e-01 | 0.005 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.893591e-01 | 0.005 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.907885e-01 | 0.004 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 9.981805e-01 | 0.001 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.987927e-01 | 0.001 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.998247e-01 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.999993e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | 0.000 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.000000e+00 | 0.000 | 1 | 1 |
| EGFR downregulation | R-HSA-182971 | 1.000000e+00 | 0.000 | 1 | 1 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 1.000000e+00 | 0.000 | 1 | 1 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 1.000000e+00 | 0.000 | 1 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 1.000000e+00 | 0.000 | 1 | 1 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.000000e+00 | 0.000 | 1 | 1 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.000000e+00 | 0.000 | 1 | 1 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.000000e+00 | 0.000 | 1 | 1 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 1.000000e+00 | 0.000 | 1 | 1 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.000000e+00 | 0.000 | 1 | 1 |
| Signaling by NOTCH3 | R-HSA-9012852 | 1.000000e+00 | 0.000 | 1 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 1.000000e+00 | 0.000 | 1 | 1 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 1.000000e+00 | 0.000 | 1 | 1 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
